Personal tools
FUNDP > Faculty of Medicine > Department of Pharmacy
 

Publications (365)

Types

2009
Potential nanotoxicity in blood : Effects of engineered nanoparticles on human blood constituents, in Nanofac 2009
Julie LALOY, Catherine MARBEHANT, Severine ROBERT, François MULLIER, Bernard CHATELAIN, Jean-Michel DOGNÉ, Olivier TOUSSAINT, Bernard MASEREEL, Stéphanie ROLIN

Serial

2009
Drug Design & Development. Drug Design of Zinc-Enzyme inhibitors: Functional, Structural, and Disease Applications: Drug Design of Carbonic anhydrase inhibitors as anticonvulsant agents. Chapter 7, pages 171-191
Anne THIRY, Jean-Michel DOGNÉ, Claudiu SUPURAN

Collective work contributions

2009
Dual carbonic anhydrase and cyclooxygenase-2 inhibition, in Drug Design of zinc-enzyme inhibitors, collection Drug Discovery & Development. , pp. 255-272
Jean-Michel DOGNÉ, Anne THIRY, Bernard MASEREEL, Claudiu SUPURAN
2009
Drug design of carbonic anhydrase inhibitors as anticonvulsant agents., in Drug-Design of Zinc-Enzyme inhibitors, collection Drug Discovery & Development. , pp. 171-191
Anne THIRY, Jean-Michel DOGNÉ, Claudiu SUPURAN, Bernard MASEREEL
2007
Chap1. Anatomie pathologique macroscopique et microscopique. in Partie 8. Techniques de laboratoire, in Traité de Médecine Légale - Beauthier-, pp. 565-602
MD PIERCECCHI-MARTI, I SALMON, K MICHAUD, K DELBECQUE, P MANGIN, Stéphanie ROLIN, F BEAUTHIER, JP BEAUTHIER

Papers

2012
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase, in Proceedings of the National Academy of Sciences, PNAS 2012 ; published ahead of print January 30, 2012, doi:10.1073/pnas.1113873109
Luc PILOTTE, Pierre LARRIEU, Vincent STROOBANT, Didier COLAU, Eduard DOLUSIC, Raphael FRÉDÉRICK, Etienne DE PLAEN, Catherine UYTTENHOVE, Johan WOUTERS, Bernard MASEREEL, Benoit VAN DEN EYNDE
2012
Discovery of pyrazolo[1,5-a]pyridines as p110alpha-selective PI3 kinase inhibitors., in Bioorganic and Medicinal Chemistry, volume 20, issue 1, pp. 69-85
J KENDALL, PD O'CONNOR, AJ MARSHALL, Raphael FRÉDÉRICK, ES MARSHALL, CL LILL, WJ LEE, S KELEKAR, M CHAO, A MALIK, S YU, C CHAUSSADE, C BUCHANAN, GW REWCASTLE, BC BAGULEY, JU FLANAGAN, SM JAMIESON, WA DENNY, PR SHEPHERD
2012
Novel pyrazolo[1,5-a]pyridines as p110alpha-selective PI3 kinase inhibitors: Exploring the benzenesulfonohydrazide SAR., in Bioorganic and Medicinal Chemistry, volume 20, issue 1, pp. 58-68
J KENDALL, A GIDDENS, KY TSANG, Raphael FRÉDÉRICK, ES MARSHALL, R SINGH, CL LILL, WJ LEE, S KOLEKAR, M CHAO, A MALIK, S YU, C CHASSUADE, C BUCHANAN, GW REWCASTLE, BC BAGULEY, JU FLANAGAN, SM JAMIESON, WA DENNY, PR SHEPHERD
2011
Synthesis and biological evaluation of novel analogues of the pan Class I phosphatidylinositol 3-kinase (PI3K) inhibitor 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474), in J Med Chem, volume 54, issue 20, pp. 7105-7126
Gordon REWCASTLE, Swarna GAMAGE, Jack FLANAGAN, Raphael FRÉDÉRICK, William DENNY, Bruce BAGULEY, Phil KESTELL, R SINGH, Jackie KENDALL, Elaine MARSHALL, C LILL, W LEE, S KOLEKAR, C BUCHANAN, S JAMIESON, Peter SHEPHERD
2011
Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal CaCo-2 cells is correlated to copper release and specific area/shape. Comparison to multi-walled carbon nanotubes, in Nanotoxicology
Jean-Pascal PIRET, Sebastien VANKONINGSLOO, Jorge Humberto MEJIA MENDOZA, Nicolas NOEL, Emmanuelle BOILAN, Françoise LAMBINON, Bernard MASEREEL, Joseph DELHALLE, Stephane LUCAS, Christelle SAOUT, Marie-Christine JACQUES-TOUSSAINT
2011
Development of a PIXE analysis method for the determination of the biopersistence of SiC and TiC nanoparticles in rat lungs, in Nanotoxicology
Omar LOZANO GARCIA, Jorge Humberto MEJIA MENDOZA, Bernard MASEREEL, Olivier TOUSSAINT, Dominique LISON, Stephane LUCAS
2011
Validation of the calibrated thrombin generation test (cTGT) as the reference assay to evaluate the procoagulant activity of nanomaterials. doi: 10.3109/17435390.2011.569096, in Nanotoxicology
Julie LALOY, Severine ROBERT, Catherine MARBEHANT, François MULLIER, Jorge Humberto MEJIA MENDOZA, Jean-Pascal PIRET, Stephane LUCAS, Bernard CHATELAIN, Jean-Michel DOGNÉ, Olivier TOUSSAINT, Bernard MASEREEL, Stéphanie ROLIN
2011
BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthase. doi: 10.1016/j.prostaglandins.2011.03.001, in Prostaglandins and Other Lipid Mediators
Céline CHERDON, Stéphanie ROLIN, Julien HANSON, OOMS, Laurence DE LEVAL, Pierre DRION, Marcelle MICHIELS, Bernard PIROTTE, Bernard MASEREEL, SAKALIHASSAN, DEFRAIGNE, Jean-Michel DOGNÉ
2011
Anti-virulence strategy against Brucella suis: Synthesis, biological evaluation and molecular modeling of selective histidinol dehydrogenase inhibitors. doi: 10.1039/C10B05149K, in Organic and Biomolecular Chemistry
Jean-Yves WYNUM, KOHLER, JOSEPH, ABDO, Jérémie MORTIER, TURTAUT, Jean-Louis MONTERO, Bernard MASEREEL
2011
Discovery and preliminary SARs of Keto-Indoles as Novel Indoleamine 2,3-Dioxygenase (IDO) Inhibitors, in European Journal of Medicinal Chemistry, volume 46, issue 7, pp. 3058-3065
Eduard DOLUSIC, Pierre LARRIEU, Sébastien BLANC, Frédéric SAPUNARIC, Jenny POUYEZ, Laurence MOINEAUX, Delphine COLETTE, Vincent STROOBANT, Luc PILOTTE, Didier COLAU, Thierry FERAIN, Graeme FRASER, Moreno GALLENI, Jean-Marie FRÈRE, Bernard MASEREEL, Benoît VAN DEN EYNDE, Johan WOUTERS, Raphael FRÉDÉRICK
2011
Tryptophan 2,3-dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators, in Journal of Medicinal Chemistry, volume 54, issue 15, pp. 5320-5334
Eduard DOLUSIC, Pierre LARRIEU, Laurence MOINEAUX, Vincent STROOBANT, Luc PILOTTE, Didier COLAU, Lionel POCHET, Benoît VAN DEN EYNDE, Bernard MASEREEL, Johan WOUTERS, Raphael FRÉDÉRICK
2011
Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors, in Bioorganic & medicinal chemistry, volume 19, pp. 134-144
Jérémy RENIERS, Severine ROBERT, Raphael FRÉDÉRICK, Bernard MASEREEL, Stephane VINCENT, Johan WOUTERS
2011
Rational design, synthesis, molecular modeling and evaluation of b-carbolines and 5H-indeno[1,2-c]pyridazin-5-one derivatives as potential MAO and IDO inhibitors
Jérémy RENIERS
2011
Erythroblastopénie, in Feuillets de Biologie, volume LII, issue 298
François MULLIER, Elisabeth MOURIN, Christian CHATELAIN, Andre BOSLY, Bernard CHATELAIN
2011
Carbon nanoparticles synthesized by sputtering and gas condensation inside a nanocluster source of fixed dimenson. doi: 10.1016/j.surfcoat.2011.03.055, in Surface and Coatings Technology, volume 205, pp. S577-S580
Virginie BOUCHAT, Olivier FERON, Bernard GALLEZ, Bernard MASEREEL, Carine MICHIELS, Thierry VANDER BORGHT, Stephane LUCAS
2011
Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indenol[1,2-c]pyridazin-5-one derivatives, in European journal of medicinal chemistry, volume 46, pp. 6104-6111
Jérémy RENIERS, Céline MEINGUET, Laurence MOINEAUX, Bernard MASEREEL, Stephane VINCENT, Raphael FRÉDÉRICK, Johan WOUTERS
2011
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors, in Bioorganic & Medicinal Chemistry, volume 19, issue 4, pp. 1550-1561
Eduard DOLUSIC, Pierre LARRIEU, Sébastien BLANC, Frédéric SAPUNARIC, Bernadette NORBERG, Laurence MOINEAUX, Delphine COLETTE, Vincent STROOBANT, Luc PILOTTE, Didier COLAU, Thierry FERAIN, Graeme FRASER, Moreno GALLENI, Jean-Marie FRÈRE, Bernard MASEREEL, Benoît VAN DEN EYNDE, Johan WOUTERS, Raphael FRÉDÉRICK
2010
A GEIL FLOW CYTOMETRY CONSENSUS PROPOSAL FOR QUANTIFICATION OF PLASMA CELLS: APPLICATION TO DIFFERENTIAL DIAGNOSIS BETWEEN MGUS AND MYELOMA, in Clinical Cytometry
Elise FREBET, Julie ABRAHAM, François MULLIER, Jean FEUILLARD
2010
Effects of leaf extracts from Croton zambesicus Muëll. Arg. on hemostasis, in Journal of Ethnopharmacology, volume 128, issue 3, pp. 641-648
Severine ROBERT, Chiara BACCELLI, Philippe DEVEL, Jean-Michel DOGNÉ, Joëlle QUETIN-LECLERCQ
2010
Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins, in Journal of Medicinal Chemistry, volume 53, pp. 335-344
Alfonso MARESCA, Claudia TEMPERINI, Lionel POCHET, Bernard MASEREEL, Andrea SCOZZAFAVA, Claudiu SUPURAN
2010
Design, solid-phase synthesis and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors, in Bioorganic and Medicinal Chemistry, volume 18, issue 21, pp. 7392-7401
Sébastien GLUSZOK, Raphael FRÉDÉRICK, Catherine FOULON, Frédérique KLUPSCH, Claudiu SUPURAN, Daniela VULLO, Andrea SCOZZAFAVA, Jean-François GOOSSENS, Bernard MASEREEL, Patrick DEPREUX, Laurence GOOSSENS
2010
Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NK-κB activation, in Biochemical pharmacology, volume 79, pp. 1462-1472
Jérémie MORTIER, Raphael FRÉDÉRICK, Corinne GANEFF, Caroline REMOUCHAMPS, Patrice TALAGA, Lionel POCHET, Johan WOUTERS, Jacques PIETTE, Emmanuel DEJARDIN, Bernard MASEREEL
2010
Méthodes de detection, quantification et caractérisation des inhibiteurs dans l'hémophilie. Forum Septembre 2009 : 9-15.
François MULLIER, Bernard CHATELAIN
2010
Definition of clinical threshold for CMV Real-Time PCR after comparison with pp65 antigenaemia and clinical data. Acta Clinica Belgica, 2009; 64-6
François MULLIER, Benoit KABAMBA, Monique BODEUS, Patrick GOUBAU
2010
Erythroblastopénie (Pure Red Cell Aplasia) . Louvain Médical Janvier 2010
Elisabeth MOURIN, François MULLIER, Christian CHATELAIN, Bernard CHATELAIN, André BOSLY
2010
Contribution of Platelet Microparticles Generation Assay to the Diagnosis of Type II Heparin-induced Thrombocytopenia. , in Thrombosis and Haemostasis, volume 103, issue 6, pp. 1277-1281
François MULLIER, Nicolas BAILLY, Yvan CORNET, Severine ROBERT, Eric DUBUC, Jean-Claude OSSELAER, Christian CHATELAIN, Jean-Michel DOGNÉ, Bernard CHATELAIN
2010
Antibody immobilization on gold nanoparticles coated layer-by-layer with polyelectrolytes (http://dx.doi.org/10.1007/s11051-010-9908-3), in Journal of Nanoparticle Research, volume 13, issue 4, pp. 1573-1580
Bernard MASEREEL, Mustapha DINGUIZLI, Nicolas MONIOTTE, Caroline BOUZIN, Olivier FERON, Bernard GALLEZ, Thierry VAN DER BORGHT, Carine MICHIELS, Stephane LUCAS
2010
NF-kappaB inducing kinase (NIK) inhibitors: identification of new scaffolds using virtual screening , in Bioorganic and Medicinal Chemistry Letters, volume 20, issue 15, pp. 4515-4520
Jérémie MORTIER, Bernard MASEREEL, Caroline REMOUCHAMPS, Corinne GANEFF, Jacques PIETTE, Raphael FRÉDÉRICK
2009
Contribution of morphology and flow cytometry to the diagnosis of angioimmunoblastic T-cell lymphoma (AILT) with blood and bone marrow involvement: a case report with literature review. Hématologie 2009; 15 (4) : 1-5
François MULLIER, Yvan CORNET, Nicolas NEYMAN, Alex DROMELET, Monique DELOS, André BOSLY, Christian CHATELAIN, Bernard CHATELAIN
2009
Phosphoinositide-3-kinase (PI3K) inhibitors: identification of new scaffolds using virtual screening, in Bioorganic and medicinal chemistry letters, volume 19, issue 20, pp. 5842-5847
Raphael FRÉDÉRICK, claire MAWSON, Jackie KENDALL, Gordon REWCASTLE, Claire CHAUSSADE, Peter SHEPHERD, William DENNY
2009
Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors, in Bioorganic and Medicinal Chemistry, volume 17, pp. 553-557
Anne THIRY, Marie LEDECQ, Alessandro CECCHI, Raphael FRÉDÉRICK, Jean-Michel DOGNÉ, Johan WOUTERS, Bernard MASEREEL, Claudiu T. SUPURAN
2009
Real-Time PCR in diagnosis of alpha-thalassemias: a future alternative? BIOTRIBUNE 2009 ; 32 : 25-28
Hassan MEKOUAR, Caroline DEBECKER, François MULLIER, Isabelle DERCLAYE, Jean-Luc VAERMAN, Marianne PHILIPPE
2009
Ir-CPI, a coagulation contact phase inhibitor from the hard tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis. , in Journal of Experimental Medecine, volume 206, issue 11, pp. 2381-2395
Yves DECREM, Géraldine RATH, Virginie BLASIOLI, Philippe CAUCHIE, Severine ROBERT, Jérôme BEAUFAYS, Jean-Marie FRÈRE, Jean-Michel DOGNÉ, Chantale DESSY, Luc VANHAMME, Edmond GODFROID
2009
Synthesis and biological evaluation of a new family of anti-benzylanilinosulfonamides as CA IX inhibitors, in European journal of medicinal chemistry, volume 44, pp. 511-518
Anne THIRY, Aurélie DELAYEN, Laurence GOOSSENS, Raymond HOUSSIN, Marie LEDECQ, Aurélie FRANKART, Jean-Michel DOGNÉ, Johan WOUTERS, Claudiu T. SUPURAN, Jean-Pierre HENICHART, Bernard MASEREEL
2009
Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model, in Radiotherapy and oncology - accepted
Ludwig DUBOIS, Natasja G. LIEUWES, Alfonso MARESCA, Anne THIRY, Claudiu T. SUPURAN, Andrea SCOZZAFAVA, Bradly G. WOUTERS, Philippe LAMBIN
2009
Conception et synthèse d'indanesulfonamides en tant qu'inhibiteurs originaux des anhydrases carboniques, in Chimie Nouvelle, issue 100, pp. 22-25
Anne THIRY, Jean-Michel DOGNÉ, Bernard MASEREEL
2009
Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs?, in Pharmacological Research, volume 59, issue 3, pp. 160-166
Severine ROBERT, Jérémie GHIOTTO, Bernard PIROTTE, Jean-Louis DAVID, Bernard MASEREEL, Lionel POCHET, Jean-Michel DOGNÉ
2008
Carbonic anhydrase inhibitors: Bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII, in Journal of Medicinal Chemistry, volume 51, issue 11, pp. 3230-3237
Katia D'AMBROSIO, Rosa-Maria VITALE, Jean-Michel DOGNÉ, Bernard MASEREEL, Alessio INNOCENTI, Andréa SCOZZAFAVA, Giuseppina DE SIMONE, Claudiu SUPURAN
2008
Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action, in Current Pharmaceutical Design, volume 14, issue 7, pp. 661-671
Anne THIRY, Jean-Michel DOGNÉ, Claudiu T. SUPURAN, Bernard MASEREEL
2008
Carbonic anhydrase inhibition insight into non-COX2 pharmacological effect of some coxibs, in Current Pharmaceutical Design, volume 14, issue 7, pp. 679-684
Jean-Michel DOGNÉ, Anne THIRY, Claudiu T. SUPURAN
2008
Molecular Modeling Approaches to the Design and Discovery of New Drugs: The Example of Phosphoinositide-3-Kinases (PI3Ks), in Chimie Nouvelle, volume 99, pp. 8-14
Raphael FRÉDÉRICK, William DENNY
2008
Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs, in Journal of Medicinal Chemistry, volume 51, issue 11, pp. 3051-3056
Anne THIRY, Claudiu T. SUPURAN, Bernard MASEREEL, Jean-Michel DOGNÉ
2008
Production and preliminary characterization of DC plasma polymerized allylamine film (PPAA) by NRA, ERD, and XPS, in Nuclear instruments and methods in physics research. B, volume 266, pp. 2494-2497
Stephane LUCAS, Gilles GENARD, Carine MICHIELS, Bernard MASEREEL, Olivier FERON, Bernard GALLEZ, Thierry VANDER BORGHT, Nicolas MOREAU
2008
Synthesis and pharmacological evaluation of a new targeted drug carrier system: beta-cyclodextrin coupled to oxytocin, in Bioorganic and Medicinal Chemistry Letters, volume 18, issue 6, pp. 1855-1858
Carine BERTOLLA, Stéphanie ROLIN, Brigitte EVRARD, Lionel POCHET, Bernard MASEREEL
2008
Carbonic anhydrase inhibitors: Binding of indanesulfonamides to the human isoform II, in ChemMedChem, volume 3, issue 3, pp. 473-477
Katia D'AMBROSIO, Bernard MASEREEL, Anne THIRY, Andréa SCOZZAFAVA, Claudiu SUPURAN, Giuseppina DE SIMONE
2008
Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors, in Journal of Medicinal Chemistry, volume 51, pp. 3077-3081
Severine ROBERT, Carine BERTOLLA, Bernard MASEREEL, Jean-Michel DOGNÉ, Lionel POCHET
2008
Indanesulfonamides as carbonic anhydrase inhibitors and anticonvulsant agents: structure-activity relationship and pharmacological evaluation, in European journal of medicinal chemistry, volume 43, pp. 2853-2860
Anne THIRY, Stéphanie ROLIN, Daniela VULLO, Aurélie FRANKART, Andrea SCOZZAFAVA, Jean-Michel DOGNÉ, Johan WOUTERS, Claudiu T. SUPURAN, Bernard MASEREEL
2007
Cardiovascular Hemodynamics and Ventriculo-Arterial Coupling in an Acute Pig Model of Ischemia-Reperfusion., in Experimental Physiolology, volume 92, issue 1, pp. 127-137
Lieve LANOYE, Patrick SEGERS, Vincent TCHANA-SATO, Stéphanie ROLIN, Jean-Michel DOGNÉ, Alexandre GHUYSEN, Bernard LAMBERMONT, Julien HANSON, Thomas DESAIVE, Vincent D'ORIO, Philippe KOLH
2007
Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX and XIV with sulfonamides incorporating fructopyranose-thioureido tails, in Bioorganic and Medicinal Chemistry Letters, volume 17, issue 10, pp. 2685-2691
Jean-Yves WINUM, Anne THIRY, Khaled EL CHEIKH, Jean-Michel DOGNÉ, Jean-Louis MONTERO, Daniela VULLO, Andrea SCOZZAFAVA, Bernard MASEREEL, Claudiu T. SUPURAN
2007
Mechanism-Based Thrombin Inhibitors: Design, Synthesis, and Molecular Docking of a New Selective 2-Oxo-2H-1-benzopyran Derivative, in Journal of Medicinal Chemistry, volume 50, pp. 3645-3650
Raphael FRÉDÉRICK, Severine ROBERT, Caroline CHARLIER, Johan WOUTERS, Bernard MASEREEL, Lionel POCHET
2007
BM-520, an original TXA2 modulator, inhibits the action of thromboxane A2 and 8-iso-prostaglandin F2alpha in vitro and in vivo on human and rodent platelets, and aortic vascular smooth muscles from rodents, in Prostaglandins & Other Lipid Mediators, volume 84, issue 1-2, pp. 14-23
Stéphanie ROLIN, Julien HANSON, Caroline VASTERSHAEGHER, Céline CHERDON, Domenico PRATICO, Bernard MASEREEL, Jean-Michel DOGNÉ
2007
Dual carbonic anhydrase - Cyclooxygenase-2 inhibitors, in Current Topics in Medicinal Chemistry, volume 7, issue 9, pp. 885-891
Jean-Michel DOGNÉ, Anne THIRY, Domenico PRATICO, Bernard MASEREEL, Claudiu T. SUPURAN
2007
Radioimmunotherapy with radioactive nanoparticles: first results of dosimetry for vascularised and necrosed solid tumors, in Medical physics, volume 34, issue 11, pp. 4504-4513
Virginie BOUCHAT, Vincent NUTTENS, Carine MICHIELS, Bernard MASEREEL, Olivier FÉRON, Bernard GALLEZ, Thierry VANDER BORGHT, Stephane LUCAS
2007
Carbonic anhydrase inhibitors as anticonvulsant agents, in Current Topics in Medicinal Chemistry, volume 7, issue 9, pp. 855-864
Anne THIRY, Jean-Michel DOGNÉ, Claudiu T. SUPURAN, Bernard MASEREEL
2007
Exploration of the binding mode of indanesulfonamides as selective inhibitors of human carbonic anhydrase type VII by targeting Lys91, in ChemMedChem, volume 2, issue 9, pp. 1273-1280
Anne THIRY, Bernard MASEREEL, Jean-Michel DOGNÉ, Claudiu T. SUPURAN, Johan WOUTERS, Catherine MICHAUX
2006
Investigation of mechanism-based thrombin inhibitors: implications of a highly conserved water molecule for the binding of coumarins within the S pocket, in Bioorganic and Medicinal Chemistry Letters, volume 16, issue 7, pp. 2017-2021
Raphael FRÉDÉRICK, Caroline CHARLIER, Severine ROBERT, Johan WOUTERS, Bernard MASEREEL, Lionel POCHET
2006
Revue critique des nouveaux principes actifs à usage humain commercialisés en Belgique au cours de la période 2001-2005, in Journal de Pharmacie de Belgique, volume 61, issue 2, pp. 45-57
Bernard MASEREEL
2006
Synthesis, structural reassignment and biological activity of type B MAO inhibitors based on the 5H-indeno-[1,2-c]pyridazin-5-one core, in Journal of Medicinal Chemistry, volume 49, issue 12, pp. 3743-3747
Raphael FRÉDÉRICK, Willy DUMONT, Frederic OOMS, Cornelis VAN DER SCHYF, Lindsey ASCHENBACH, Neal CASTAGNOLI, Johan WOUTERS, Alain KRIEF
2006
Indanesulfonamides as carbonic anhydrase inhibitors: toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX, in Journal of Medicinal Chemistry, volume 49, issue 9, pp. 2743-2749
Anne THIRY, Marie LEDECQ, Alessandro CECCHI, Jean-Michel DOGNÉ, Johan WOUTERS, Claudiu T. SUPURAN, Bernard MASEREEL
2006
Synthesis, molecular modelling and enzymatic evaluation of (±) 3,5-diphenyl-2-thioxoimidazolidin-4-ones as new potential cyclooxygenase inhibitors, in Bioorganic and Medicinal Chemistry, volume 14, issue 4, pp. 918-927
Marie-Pierre GAUTHIER, Catherine MICHAUX, Stéphanie ROLIN, Caroline VASTERSAEGHER, Xavier DE LEVAL, Fabien JULÉMONT, Lionel POCHET, Bernard MASEREEL
2006
Targeting tumor-associated carbonic anhydrase IX in cancer therapy, in Trends in Pharmacological Sciences, volume 27, issue 11, pp. 566-573
Anne THIRY, Jean-Michel DOGNÉ, Bernard MASEREEL, Claudiu T. SUPURAN
2006
Prostanoid as pharmacological targets in COPD and asthma, in European Journal of Pharmacology, volume 533, pp. 89-100
Stéphanie ROLIN, Bernard MASEREEL, Jean-Michel DOGNÉ
2006
Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion, in Prostanglandins and Other Lipid Mediators, volume 79, issue 1-2, pp. 53-73
Philippe KOLH, Stéphanie ROLIN, Vincent TCHANA-SATO, Michel PÉTEIN, Alexandre GHUYSEN, Bernard LAMBERMONT, Julien HANSON, David MAGIS, Patrick SEGERS, Bernard MASEREEL, Vincent D'ORIO, Jean-Michel DOGNÉ
2005
Selective cyclooxygenase-2 inhibitors development in cardiovascular medicine, in Circulation, volume 112, issue 7, pp. 1073-9
D PRATICO, Jean-Michel DOGNÉ
2005
Modulators of the coagulation cascade: Focus and Recent Advances in Inhibitors of Tissue Factor, Factor VIIa and their complex, in Current Medicinal Chemistry, volume 12, issue 4, pp. 397-417
Raphael FRÉDÉRICK, Lionel POCHET, Caroline CHARLIER, Bernard MASEREEL
2005
A model of porcine myocardial-infarction induced by progressive coronary-artery thromobosis provoked by ferric-chlorade, in Hypertension, volume 46, pp. 911-911
Jean-Michel DOGNÉ, Stéphanie ROLIN, V TCHANA-SATO, M PETEIN, A GHUYSEN, B LAMBERMONT, J HANSON, V DORIO, R LIMET, P KOLH
2005
(E)-8-(3-Chlorostyryl)-1,3,7-trimethylxanthine, a caffeine derivative acting both as antagonist of adenosine A2A receptors and as inhibitor of MAO-B, in Acta crystallographica. Section C: Crystal structure communications, volume C61, pp. 531-532
Raphael FRÉDÉRICK, Frédéric OOMS, Neal CASTAGNOLI JR., Jacques PETZER, Jiang-Fan FENG, Michael SCHWARZSCHILD, Cornelis VAN DER SCHYF, Johan WOUTERS
2005
3,6-disubstituted coumarins as mechanism based inhibitors of Thrombin and Factor Xa, in Journal of Medicinal Chemistry, volume 48, pp. 7592-7603
Raphael FRÉDÉRICK, Severine ROBERT, Caroline CHARLIER, Jerome DE RUYCK, Johan WOUTERS, Bernard PIROTTE, Bernard MASEREEL, Lionel POCHET
2005
Effects of reperfusion on left ventricular hemodynamics and ventriculo-arterial coupling in acutely ischemic pigs, in Computer Methods in Biomechanics and Biomedical Engeineering, volume 8, pp. 169-170
Lieve LANOYE, Philippe KOLH, Stéphanie ROLIN, Vincent TCHANA-SATO, Jean-Michel DOGNÉ, Alexandre GHUYSEN, Bernard LAMBERMONT, David MAGIS, Julien HANSON, Patrick SEGERS, P GERARD, Bernard MASEREEL, Vincent D'ORIO, Raymond LIMET
2005
Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitor, in Cardiovascular Drug Reviews, volume 23, pp. 1-14
Alexandre GHUYSEN, Jean-Michel DOGNÉ, Patrice CHIAP, Stéphanie ROLIN, Bernard MASEREEL, Bernard LAMBERMONT, Philippe KOHL, Vincent TCHANA-SATO, Julien HANSON, Vincent DORIO
2005
Nouveaux principes actifs commercialisés en 2004 au sein de spécialités pharmaceutiques à usage humain, in Journal de Pharmacie de Belgique, volume 60, pp. 1-16
Bernard MASEREEL
2005
In vitro and in vivo pharmacological characterization of BM-613, a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in Journal of Pharmacology and Experimental Therapeutics, volume 313, issue 1, pp. 293-301
Julien HANSON, Stéphanie ROLIN, D REYNAUD, N QIAO, L KELLEY, H REID, F VALENTIN, J TIPPINS, T KINSELLA, Bernard MASEREEL, C PACE-ASCIAK, Bernard PIROTTE, Jean-Michel DOGNÉ
2005
Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pig, in Thrombosis Research, volume 116, issue 5, pp. 431-442
Jean-Michel DOGNÉ, Marie-Pierre ROLIN, Michel PETEIN, Vincent TCHANA-SATO, Alexandre GHUYSEN, Bernard LAMBERMONT, Julien HANSON, David MAGIS, Patrick SEGERS, Bernard PIROTTE, Bernard MASEREEL, Pierre DRION, Vincent D'ORIO, Philippe KOLH
2004
Coumarins and isocoumarins as serine protease inhibitors, in Current Pharmaceutical Design, volume 10, pp. 3781-3796
Lionel POCHET, Raphael FRÉDÉRICK, Bernard MASEREEL
2004
Nouvelles entités chimiques entrant dans la composition de spécialités commercialisées en Belgique en 2003, in Journal de Pharmacie de Belgique, volume 59, issue 1, pp. 1-12
Bernard MASEREEL
2004
Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity, in Bioorganic and Medicinal Chemistry, volume 12, issue 10, pp. 2717-2726
Marc ILIES, Bernard MASEREEL, Stéphanie ROLIN, Andrea SCOZZAFAVA, G CAMPEANU, V CIMPEANU, Claudiu SUPURAN
2004
New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators, in Current Medicinal Chemistry, volume 11, issue 10, pp. 1243-1252
Xavier DE LEVAL, Julien HANSON, Jean-Louis DAVID, Bernard MASEREEL, Bernard PIROTTE, Jean-Michel DOGNÉ
2004
Effect of a novel thromboxane A2 inhibitor on right ventricular-arterial coupling in endotoxic shock, in Shock, volume 21, issue 1, pp. 45-51
Bernard LAMBERMONT, Philippe KOHL, Alexandre GHUYSEN, Patrick SEGHERS, Jean-Michel DOGNÉ, Vincent TCHAN-SATO, Philippe MORIMONT, Patricia BENOIT, P GERARD, Bernard MASEREEL, Vincent D'ORIO
2004
New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators, in Current Medicinal Chemistry, volume 11, issue 10, pp. 1223-1241
Jean-Michel DOGNÉ, Xavier DE LEVAL, Julien HANSON, Michel FREDERICH, Bernard LAMBERMONT, Alexandre GHUYSEN, Angela CASINI, Bernard MASEREEL, KH RUAN, Bernard PIROTTE, Philippe KOLH
2004
Design synthesis and pharmacological evaluation of pyridinic analogs of nimesulide as cyclooxygenase-2 slective inhibitors, in Journal of Medicinal Chemistry, volume 47, issue 27, pp. 6749-6759
F JULEMONT, X DELEVAL, Catherine MICHAUX, JF RENARD, JY WYNUM, JL MONTERO, Jean-Michel DOGNÉ, J DAMAS, B PIROTTE
2004
Pharmacological Characterization of N-tert-Butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects, in Journal of Pharmacology and Experimental Therapeutics, volume 309, issue 2, pp. 498-505
Jean-Michel DOGNÉ, Julien HANSON, Xavier DE LEVAL, Philippe KOHL, Vincent TCHANA-SATO, Laurence DE LEVAL, Stéphanie ROLIN, Alexandre GHUYSEN, Patrick SEGERS, Bernard LAMBERMONT, Bernard MASEREEL, Bernard PIROTTE
2004
Carbonic anhydrase inhibitors - Design of anticonvulsant sulfonamides incorporating indane moieties, in Bioorganic and Medicinal Chemistry Letters, volume 14, pp. 5781-5786
Celine CHAZALETTE, Bernard MASEREEL, Stéphanie ROLIN, Anne THIRY, Andrea SCOZZAFAVA, Alessio INNOCENTI, Claudiu T. SUPURAN
2004
Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors, in Prostaglandins & Other Lipid Mediators, volume 74, pp. 75-86
Stéphanie ROLIN, Jean-Michel DOGNÉ, Caroline VASTERSAEGHER, Julien HANSON, Bernard MASEREEL
2004
New developments on thromboxane modulators, in Mini-Reviews in Medecinal Chemistry, volume 4, pp. 649-657
Jean-Michel DOGNÉ, Julien HANSON, Xavier DE LEVAL, Bernard MASEREEL, Philippe KOHL, Bernard PIROTTE
2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II): effects of BM-567 on platelet function, in Prostaglandins Leukotrienes and Essential Fatty Acids, volume 68, pp. 49-54
Jean-Michel DOGNÉ, Xavier DE LEVAL, Philippe KOHL, V. SANNA, Stéphanie ROLIN, Catherine MICHAUX, M. MAUER, Jean-Louis DAVID, Bernard MASEREEL, Bernard PIROTTE
2003
Effects of endotoxic shock on right ventricular systolic function and mechanical efficiency, in Cardiovascular Research, volume 59, pp. 412-418
Bernard LAMBERMONT, A GHUYSEN, Philippe KOLH, Vincent TCHANA-SATO, P SEGERS, P GÉRARD, Philippe MORIMONT, D MAGIS, Jean-Michel DOGNÉ, Bernard MASEREEL, Vincent D'ORIO
2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation, in Prostaglandins Leukotrienes and Essential Fatty Acids, volume 68, pp. 55-59
Xavier DE LEVAL, Valérie BENOIT, Jacques DELARGE, Fabien JULÉMONT, Bernard MASEREEL, Benard PIROTTE, Marie-Paule MERVILLE, Jean-Louis DAVID, Jean-Michel DOGNÉ
2003
Effects of U-46619 on pulmonary hemodynamics before and after administration of BM-573, a novel thromboxane A2 inhibitor, in Arch Physiol Biochem, volume 111, issue 3, pp. 217-223
Bernard LAMBERMONT, Phillipe KOHL, Jean-Michel DOGNÉ, Alexandre GHUYSEN, Vincent TCHANA-SATO, Philippe MORIMONT, Patricia BENOIT, P GÉRARD, Bernard MASEREEL, Raymond LIMET, Vincent D'ORIO
2003
3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell invasion in vitro and tumour growth in vivo, in British Journal of Cancer, volume 88, pp. 1111-1118
Isabelle KEMPEN, D PAPAPOSTOLOU, Nicole THIERRY, Lionel POCHET, Stéphane COUNEROTTE, Bernard MASEREEL, Jean-Michel FOIDART, Michèle REBOUD-RAVAUX, Agnès NOEL, Bernard PIROTTE
2003
Nouveaux principes actifs entrant dans la composition de spécialités pharmaceutiques commercialisées en 2002, in Journal de Pharmacie de Belgique, volume 58, pp. 1-20
Bernard MASEREEL
2003
BM-573, a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist Prevents Pig Myocardial Infarction Induced by Coronary Thrombosis, in Journal of Pharmacology and Experimental Therapeutics, volume 306, pp. 59-65
Stéphanie ROLIN, Michel PETEIN, Vincent TCHANA-SATO, Jean-Michel DOGNÉ, Patricia BENOIT, Bernard LAMBERMONT, Alexandre GHUYSEN, Philippe KOHL, Bernard MASEREEL
2003
An overview of inhibitors of Na+/H+ exchanger, in European Journal of Medicinal Chemistry, volume 38, pp. 547-554
Bernard MASEREEL, Lionel POCHET, Didier LAECKMANN
2003
Investigation of the inhibition mechanism of coumarins on chymotrypsin by mass spectrometry, in Tetrahedron, volume 59, pp. 4557-4561
Lionel POCHET, Marc DIEU, Raphael FRÉDÉRICK, Anne-Marie MURRAY, Isabelle KEMPEN, Bernard PIROTTE, Bernard MASEREEL
2003
A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors, in European Journal of Medicinal Chemistry, volume 38, pp. 703-710
Catherine MICHAUX, Jean-Michel DOGNÉ, Stéphanie ROLIN, Bernard MASEREEL, Johan WOUTERS, François DURANT
2002
Structural approach of the mechanism of inhibition of a-chymotrypsin by coumarins, in Bioorganic & Medicinal Chemistry Letters, volume 12, issue 7, pp. 1109-1112
Johan WOUTERS, Marjorie HUYGENS, Lionel POCHET, Bernard PIROTTE, François DURANT, Bernard MASEREEL
2002
Synthesis and biological evaluation of aroylguanidines related to amiloride as inhibitors of the human platelet Na+/H+ exchanger, in Bioorganic & Medicinal Chemistry, volume 10, issue 6, pp. 1793-1804
Didier LAECKMANN, Françoise ROGISTER, Jean-Victor DEJARDIN, Christelle PROSPERI-MEYS, Joseph GÉCZY, Jacques DELARGE, Bernard MASEREEL
2002
Therapeutic potential of thromboxane inhibitors in asthma, in Expert Opinion on Investigational Drugs, volume 11, pp. 1-8
Jean-Michel DOGNÉ , Xavier DE LEVAL, Patricia BENOIT, Stéphanie ROLIN, Bernard PIROTTE, Bernard MASEREEL
2002
K-ATP channel openers for the treatment of breast and endometrial cancer, in Expert opinion on Therapeutic Patents, volume 12, pp. 1111-1113
Bernard MASEREEL
2002
N-tert-Butyl-N'-(2-cyclohexylamino-5-nitrobenzenesulfonyl)urea, BM531, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition, in Acta crystallographica. Section C: Crystal structure communications, issue C58, pp. 621-623
Catherine MICHAUX, Jean-Michel DOGNÉ, Bernadette NORBERG, François DURANT, Bernard MASEREEL
2002
Carbonic Anhydrase Inhibitors: Anticonvulsant Sulfonamides Incorporating Valproyl and Other Lipophilic Moieties, in Journal of Medicinal Chemistry, volume 45, pp. 312-320
Bernard MASEREEL, Stéphanie ROLIN, Francesco ABBATE, Andrea SCOZZAFAVA, Claudiu SUPURAN
2002
Thromboxane A2 inhibition : Therapeutic potential in bronchial asthma., in American Journal of Respiratory Medicine, volume 1, pp. 11-17
Jean-Michel DOGNÉ, Xavier DE LEVAL, Patricia BENOÎT, Jacques DELARGE, Bernard MASEREEL
2002
Recent advances in antiplatelet agents, in Current Medicinal Chemistry, volume 9, pp. 577-589
Jean-Michel DOGNÉ, Xavier DE LEVAL, P BENOÎT, Jacques DELARGE, Bernard MASEREEL, Jean-Louis DAVID
2002
In vitro and in vivo effects of new insulin releasing agents, in Biochemical Pharmacology, volume 63, issue 3, pp. 515-521
Quynh-Anh NGUYEN, Marie-Hélène ANTOINE, Raogo OUEDRAOGO, Marcel HERMANN, Jacqueline SERGOORIS, Bernard PIROTTE, Bernard MASEREEL, Philippe LEBRUN
2002
New active agents. The composition of commercial pharmaceutical specialities in 2001, in Journal de Pharmacie de Belgique, volume 57, pp. 1-13
Bernard MASEREEL
2001
Activity of a novel dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles., in Prostaglandins Leukotrienes and Essential Fatty Acids, volume 65, pp. 67-72
Stéphanie ROLIN, Jean-Michel DOGNÉ, Catherine MICHAUX, Jacques DELARGE, Bernard MASEREEL
2001
Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood, in Prostaglandins Leukotrienes and Essential Fatty Acids, volume 64, pp. 211-216
Xavier DE LEVAL, Jacques DELARGE, Philippe DEVEL, Phillipe NEVEN, Catherine MICHAUX, Bernard MASEREEL, Bernard PIROTTE, Jean-Louis DAVID, Yves HENROTIN, Jean-Michel DOGNÉ
2001
Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531, in Cardiovascular Drug Reviews, volume 19, pp. 87-96
Jean-Michel DOGNÉ, Stéphanie ROLIN, Xavier DE LEVAL, Phillipe NEVEN, Jacques DELARGE, Philippe KOLH, Jacques DAMAS, Jean-Louis DAVID, Bernard MASEREEL
2001
Synthesis of nimesulide nanoparticles in the microemulsion epikuron/isopropyl myristate/water/n-butanol (or isopropanol), in Journal of Colloid and Interface Science, volume 243, pp. 90-101
Fabienne DEBUIGNE, Jérémie CUISENAIRE, Laurence JEUNIEAU, Bernard MASEREEL, Janos B.NAGY
2001
Nouveaux Médicaments. Principes actifs entrant dans la composition de spécialités pharmaceutiques commercialisées en 2000., in Journal de Pharmacie de Belgique, volume 56, pp. 1-32
Jeanine OSLET, Bernard MASEREEL
2001
Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, in Journal of Pharmacy and Pharmacology, issue 53, pp. 669-680
Jean-Michel DOGNÉ, Johan WOUTERS, Stéphanie ROLIN, Catherine MICHAUX, Lionel POCHET, François DURANT, Jacques DELARGE, Bernard MASEREEL
2001
Structure determination and comparison of BM567, a sulfonylurea, with Terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition, in Bioorganic and Medicinal Chemistry Letters, issue 11, pp. 1019-1022
Catherine MICHAUX, Stéphanie ROLIN, Jean-Michel DOGNÉ, François DURANT, Bernard MASEREEL, Jacques DELARGE, Johan WOUTERS
2001
Recent developments of thromboxane modulators, in Expert Opinion on Therapeutic Patents, volume 11, pp. 1663-1675
Jean-Michel DOGNÉ, Xavier DE LEVAL, Jacques DELARGE, Bernard MASEREEL
2001
Novel inhibitors of sodium-calcium exchanger: benzene ring analogues of N-guanidino substituted amiloride derivatives., in European Journal of Medicinal Chemistry, volume 36, pp. 597-614
Françoise ROGISTER, Didier LAECKMANN, PO PLASMAN, F VAN EYLEN, M GHYOOT, C MAGGETTO, Jean-François LIÉGEOIS, Jozef GECZY, André HERCHUELZ, Jacques DELARGE, Bernard MASEREEL
2000
Synthesis of monodisperse nimesulide nanoparticles in microemulsions E 170/isopropyl myristate/water/n-butanol (or isopropanol)., in Journal de Pharmacie de Belgique, volume 55, pp. 59-60
Fabienne DEBUIGNE, Jérémie CUISENAIRE, Laurence JEUNIEAU, Janos B.NAGY, Bernard MASEREEL
2000
Pharmacomodulation studies of torasemide led to original non-carboxylic thromboxane A2 receptor antagonists, in Pharmacy and Pharmacology Communication, volume 6, pp. 77-82
Jean-Michel DOGNÉ, Xavier DE LEVAL, Philippe NEVEN, Stéphanie ROLIN, Fabian SOMERS, Johan WOUTERS, Jacques DELARGE, Bernard MASEREEL
2000
Coumarinic derivatives as mechanism-based inhibitors of &-chymotrypsin and human leukocyte elastase, in Bioorganic and Medicinal Chemistry, issue 8, pp. 1489-1501
Lionel POCHET, Caroline DOUCET, Georges DIVE, Johan WOUTERS, Bernard MASEREEL, Michèle REBOUD-RAVAUX, Bernard PIROTTE
2000
Isosterism among analogues of torasemide: conformational, electronic and lipophilic properties, in European Journal of Medicinal Chemistry, volume 35, pp. 923-929
Johan WOUTERS, Catherine MICHAUX, François DURANT, Jean Michel DOGNÉ, Jacques DELARGE, Bernard MASEREEL
2000
New Trends in Thromboxane and Prostacyclin Modulators, in Current Medicinal Chemistry , volume 7, pp. 609-628
Jean-Michel DOGNÉ, Xavier DE LEVAL, Jacques DELARGE, Jean-Louis DAVID, Bernard MASEREEL
2000
Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition, in Acta crystallographica Section C: Crystal Structure communications, issue 56, pp. 1265-1266
Catherine MICHAUX, Bernadette NORBERG, Jean-Michel DOGNÉ, François DURANT, Bernard MASEREEL, Jacques DELARGE, Johan WOUTERS
2000
Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet function, in Prostaglandins Leukotrienes and Essential Fatty Acids, volume 62, pp. 311-317
Jean-Michel DOGNÉ, Xavier DE LEVAL, Philippe NEVEN, Stéphanie ROLIN, Johan WOUTERS, Jean-Louis DAVID, Jacques DELARGE, Bernard MASEREEL
2000
Comparison of the effects of nimesulide and nimesulide-L-lysine on PGE2 production by COX-1 and COX-2 and on chondrocyte metabolism in-vitro, in Pharmacy and Pharmacology Communication, volume 6, pp. 83-87
Xavier DE LEVAL, Yves HENROTIN, A LABASSE, Jean-Yves REGINSTER, Philippe NEVEN, Jacques DELARGE, Fabian SOMERS, Bernard MASEREEL, Bernard PIROTTE, Jean-Michel DOGNÉ
2000
Nouveaux principes actifs entrant dans la composition de spécialités pharmaceutiques commercialisées en 1999, in Journal de Pharmacie de Belgique, volume 55, pp. 1-29
Jeanine OSLET, Bernard MASEREEL
1999
Synthesis, structural characterization and thromboxane A2 receptor antagonistic activity of 3-substituted 2-[arylsulfonyl)imino]-2,3-dihydrothiazolyl derivatives., in European Journal of Medicinal Chemistry, volume 34, pp. 311-328
Fabrice LACAN, Martine VARACHE-LEMBÈGE, J VERCAUTEREN, JM LÉGER, Bernard MASEREEL, Jean-Michel DOGNÉ, Alain NUHRICH
1999
Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500), in Journal of Pharmacy and Pharmacology, volume 51, pp. 695-701
Bernard MASEREEL, Jacques DAMAS, Jeanine FONTAINE, Martine LEMBÈGE, Fabrice LACAN, Alain NUHRICH, Jacques DELARGE, Lionel POCHET, Jean-Michel DOGNÉ
1999
P-glycoprotein inhibition by glibenclamide and related compounds., in Pflugers Archiv / European Journal of Physiology, volume 437, pp. 652-660
PE GOLSTEIN, A BOOM, J VAN GEFFEL, P JACOBS, Bernard MASEREEL, Renaud BEAUWENS
1999
Evidence for a neuroprotective effect of pyrid-3-yl-sulphonyl-urea in photochemically induced focal ischemia in rats : magnetic resonance imaging evaluation, in Journal of Pharmacy and Pharmacology, volume 51, pp. 967-970
C BAUDELET, R DEMEURE, A FROIS, Bernard MASEREEL, JF GOUDEMANT, C RITTER, Bernard GALLEZ
1999
6-Substituted 2-Oxo-2H-1-benzopyran-3-carboxylic Acid as a Core Structure for Specific Inhibitors of Human Leukocyte Elastase, in Journal of Medicinal Chemistry, volume 42, pp. 4161-4171
C DOUCET, Lionel POCHET, N THIERRY, B PIROTTE, J DELARGE, M REBOUD-RAVAUX
1999
Insulinotropic effect of new glibenclamide isosteres, in Journal of Pharmacology and Experimental Therapeutics, volume 289, pp. 625-631
R OUEDRAOGO, QA NGUYEN, Marie-Hélène ANTOINE, C KANE, MJ DUNNE, Lionel POCHET, Bernard MASEREEL, Philippe LEBRUN
1999
Antagonism of the TXA2 receptor by seratrodast: a structural approach, in Bioorganic and Medicinal Chemistry Letters, volume 9, pp. 2867-2870
Johan WOUTERS, François DURANT, Bernard MASEREEL
1998
"Fries like" rearrangement : a novel and efficient method for the synthesis of 6-acyl-2(3H)-benzoxazolones and 6-acyl-2(3H)-benzothiazolones., in Tetrahedron, volume 54, pp. 1763-1772
H UCAR, K VAN DERPOORTEN, Paul DEPOVERE, Daniel LESIEUR, M ISA, Bernard MASEREEL, J. DELARGE, Jacques POUPAERT
1998
Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives, in Journal of Medecinal Chemistry, volume 41, pp. 1138-1145
H UCAR, K VAN DERPOORTEN , S CACCIAGUERRA, S SPAMPINATO, S STABLES, Paul DEPOVERE, M ISA, Bernard MASEREEL, Jacques DELARGE, Jacques POUPAERT
1998
Anticonvulsant Activity and Interactions with Neuronal Voltage-Dependent Sodium Channel of Analogues of Ameltolide, in Journal of Medicinal Chemistry, volume 41, pp. 3307-3313
Jacques VAMECQ, Didier LAMBERT, Jacques POUPAERT, Bernard MASEREEL, J.P. STABLES
1998
Design, Synthesis and Anticonvulsant Activity of 1-(Pyrid-3-ylsulfonamido)-2-nitroethylenes, in Journal of Medicinal Chemistry, volume 41, issue 17, pp. 3239-3244
Bernard MASEREEL, Johan WOUTERS, Lionel POCHET, Didier LAMBERT
1998
Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands : synthesis and biological evaluation, in European Journal of Pharmaceutical Sciences, volume 7, pp. 29-40
Bernard PIROTTE, Pascal DE TULLIO, Tchao PODONA, Ousman DIOUF, Daniel DEWALQUE, Philippe NEVEN, Bernard MASEREEL, Daniel Henri CAIGNARD, Pierre RENARD, Jacques DELARGE
1997
Anticonvulsant activity of pyrid-3-yl-sulfonyl urea and thiourea., in Epilepsia, volume 38, pp. 334-337
Bernard MASEREEL, Didier LAMBERT, Jean-Michel DOGNÉ, Jacques POUPAERT, Jacques DELARGE
1997
Synthesis and Biological Evaluation of Sulfonylcyanoguanidines and Sulfonamidonitroethylenes as Bioisosteres of Hypoglycemic sulfonylureas., in European Journal of Medicinal Chemistry, volume 32, pp. 453-456
Bernard MASEREEL, R OUEDRAOGO, Jean-Michel DOGNÉ, Marie-Hélène ANTOINE, Pascal DE TULLIO, Bernard PIROTTE, Lionel POCHET, Jacques DELARGE, Philippe LEBRUN

Conference Proceedings

2011
Indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2,3- dioxygenase (IDO), a promising target for anti-cancer immunotherapy, in Book of Abstracts, 47èmes RICT, 6-8 juillet 2011, Lyon, France, volume IS08, pp. 136-136
Eduard DOLUSIC, Pierre LARRIEU, Sébastien BLANC, Laurence MOINEAUX, Frédéric SAPUNARIC, Jenny POUYEZ, Delphine COLETTE, Graeme FRASER, Vincent STROOBANT, Luc PILOTTE, Didier COLAU, Jean-Marie FRÈRE, Bernard MASEREEL, Benoît VAN DEN EYNDE, Johan WOUTERS, Raphael FRÉDÉRICK
2011
A CONVENIENT FORMATION OF HIGHLY FUNCTIONALIZED 5-BROMO-1,3-THIAZOLES., in Book of Abstracts, 15th Sigma-Aldrich Organic Synthesis Meeting, Spa, Belgium, 1-2 December 2011, pp. 25-25
Eduard DOLUSIC, Sara MODAFFARI, Johan WOUTERS, Bernard MASEREEL, Raphael FRÉDÉRICK
2011
Novel Inhibitors of Indoleamine 2,3-Dioxygenase (IDO), a Target for Anti-Cancer Immunotherapy, in Book of Abstracts, XVIIIème Journée Jeunes Chercheurs, 04/02/11, Paris, France
Eduard DOLUSIC, Sébastien BLANC, Pierre LARRIEU, Laurence MOINEAUX, Delphine COLETTE, Graeme FRASER, Vincent STROOBANT, Luc PILOTTE, Didier COLAU, Johan WOUTERS, Bernard MASEREEL, Benoît VAN DEN EYNDE, Raphael FRÉDÉRICK
2011
Indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2,3-dioxygenase (IDO), a promising target for anti-cancer immunotherapy, in Book of Abstracts, 25èmes Journées Franco-belges de Pharmacochimie, 19-20/05/11, Liège, volume P37, pp. 62-62
Eduard DOLUSIC, Pierre LARRIEU, Sébastien BLANC, Laurence MOINEAUX, Delphine COLETTE, Graeme FRASER, Vincent STROOBANT, Luc PILOTTE, Didier COLAUX, Johan WOUTERS, Bernard MASEREEL, Benoît VAN DEN EYNDE, Raphael FRÉDÉRICK
2011
Synthesis, structural, enzymatic and cellular studies of vinyl-1H-indole analogues as potential inhibitors of tryptophan 2,3-dioxygenase (TDO), an attractive target in cancer immunotherapy., in Book of Abstracts, Emerging Targets and Treatments: Opportunities and Challenges for Drug Design, Ghent, 25 November 2011, volume P22
Laurence MOINEAUX, Caroline CHARLIER, Eduard DOLUSIC, Pierre LARRIEU, Luc PILOTTE, Didier COLAU, Vincent STROOBANT, Paulette CHARLIER, Sophie LAURENT, Moreno GALLENI, Bernard MASEREEL, Benoît VAN DEN EYNDE, Johan WOUTERS, Raphael FRÉDÉRICK
2011
LECTURE: Indoleamine 2,3-Dioxygenase Inhibitory Activity of Derivatives of Marine Alkaloid Tsitsikammamine A, in Book of Abstracts, 25èmes Journées Franco-belges de Pharmacochimie, 19-20/05/11, Liège, volume OC10, pp. 22-22
Eduard DOLUSIC, Pierre LARRIEU, Delphine COLETTE, Sébastien BLANC, Arnaud RIVES, Graeme FRASER, Johan WOUTERS, Robert KISS, Benoît VAN DEN EYNDE, Bernard MASEREEL, Evelyne DELFOURNE, Raphael FRÉDÉRICK
2011
THIOSEMICARBAZONES AS INHIBITORS OF TRYPTOPHAN 2,3-DIOXYGENASE (TDO), AN EMERGING TARGET FOR CANCER TREATMENT, in Book of Abstracts, Emerging Targets and Treatments: Opportunities and Challenges for Drug Design, Ghent, 25 November 2011, volume P21
Eduard DOLUSIC, Sara MODAFFARI, Pierre LARRIEU, Christelle VANCRAEYNEST, Luc PILOTTE, Didier COLAU, Vincent STROOBANT, Benoît VAN DEN EYNDE, Johan WOUTERS, Bernard MASEREEL, Raphael FRÉDÉRICK
2011
coauthor on lecture: Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase (TDO): discovery of an orally active TDO inhibitor., in Book of Abstracts, Emerging Targets and Treatments: Opportunities and Challenges for Drug Design, Ghent, 25 November 2011, volume OC01
Eduard DOLUSIC, Pierre LARRIEU, Laurence MOINEAUX, Vincent STROOBANT, Luc PILOTTE, Didier COLAU, Benoît VAN DEN EYNDE, Bernard MASEREEL, Johan WOUTERS, Raphael FRÉDÉRICK
2011
Discovery and preliminary SARs of new scaffolds of tryptophan 2,3-dioxygenase (TDO) inhibitors using virtual screening, in Book of Abstracts, 25èmes Journées Franco-belges de Pharmacochimie, 19-20/05/11, Liège, volume P19, pp. 44-44
Laurence MOINEAUX, Caroline CHARLIER, Eduard DOLUSIC, Pierre LARRIEU, Luc PILOTTE, Didier COLAU, Vincent STROOBANT, Moreno GALLENI, Bernard MASEREEL, Benoît VAN DEN EYNDE, Johan WOUTERS, Raphael FRÉDÉRICK
2011
SYNTHESIS, ACTIVITY, CRYSTAL AND ELECTRONIC PROPERTIES OF ISOMERS OF CHLORO-PYRIDINYLVINYL-1H-INDOLES, in Book of Abstracts, 25èmes Journées Franco-belges de Pharmacochimie, 19-20/05/11, Liège, volume P20, pp. 45-45
Laurence MOINEAUX, Sophie LAURENT, Eduard DOLUSIC, Jérémy RENIERS, Bernadette NORBERG, Jean-Marie FRÈRE, Moreno GALLENI, Benoît VAN DEN EYNDE, Bernard MASEREEL, Raphael FRÉDÉRICK, Johan WOUTERS
2011
AROMATIC THIOSEMICARBAZONES ARE INHIBITORS OF TRYPTOPHAN 2,3-DIOXYGENASE (TDO), AN EMERGING TARGET FOR CANCER TREATMENT, in Book of Abstracts, 4th International Symposium on Advances in Synthetic and Medicinal Chemistry (ASMC 11), St. Petersburg, Russia, August 21-25, 2011, volume P157, pp. 270-270
Eduard DOLUSIC, Sara MODAFFARI, Pierre LARRIEU, Christelle VANCRAEYNEST, Luc PILOTTE, Didier COLAU, Vincent STROOBANT, Johan WOUTERS, Bernard MASEREEL, Benoît VAN DEN EYNDE, Raphael FRÉDÉRICK
2010
Introduction to microparticles: 2010 and future, in Sta user's meeting, Paris
François MULLIER, Nicolas BAILLY, Jean-Michel DOGNÉ, Bernard CHATELAIN
2010
Tryptophan 2,3-dioxygenase (TDO) inhibitors : Identification of new scaffolds using virtual screening, in Abstracts, Journée scientifique de la Société royale de chimie (SRC), Gembloux, Belgium, 14 October 2010
Laurence MOINEAUX, Caroline CHARLIER, Eduard DOLUSIC, Pierre LARRIEU, Luc PILOTTE, Didier COLAU, Vincent STROOBANT, Moreno GALLENI, Bernard MASEREEL, Benoît VAN DEN EYNDE, Johan WOUTERS, Raphael FRÉDÉRICK
2010
Microparticle Generation Assay: a new tool to diagnose and study the physiopathology of type-II HIT, in 56th Annual Scientific and StandardizationCommittee Meeting (SSC) of the International Society of Thrombosis and Hemostasis (ISTH), Cairo
François MULLIER, Nicolas BAILLY, Yvan CORNET, Eric DUBUC, Séverine ROBERT, Jean-Claude OSSELAER, Christian CHATELAIN, Ismail ELALAMY, Jean-Michel DOGNÉ, Bernard CHATELAIN
2010
Conception, synthèse et étude d'inhibiteurs de la tryptophane 2,3-dioxygénase (TDO), une cible prometteuse pour le traitement du cancer, in Abstracts, Séminaire des jeunes chercheurs Télévie 2011, Brussels, Belgium, 7 December 2010
Laurence MOINEAUX, Caroline CHARLIER, Eduard DOLUSIC, Pierre LARRIEU, Luc PILOTTE, Didier COLAU, Vincent STROOBANT, Moreno GALLENI, Bernard MASEREEL, Benoît VAN DEN EYNDE, Johan WOUTERS, Raphael FRÉDÉRICK
2010
SYSTEMIC IMMUNE RESPONSE DURING THE EARLY PHASE OF WOUND HEALING AFTER SINUS SURGERY, in Belgian Rhinology Society 2010
Jean-Baptiste WATELET, François MULLIER, Yvan CORNET, Philippe ELOY, Youri GLUPCZYNSKI, Bernard CHATELAIN
2010
Platelet Microparticle Generation Assay: a valuable and simpler alternative to 14C-SRA for type-II HIT diagnosis: selection for oral presentation, in European Society for Clinical Cell Analysis, Valencia, September 2010
François MULLIER, Nicolas BAILLY, Yvan CORNET, Eric DUBUC, Séverine ROBERT, Jean-Claude OSSELAER, Christian CHATELAIN, Ismail ELALAMY, Jean-Michel DOGNÉ, Bernard CHATELAIN
2010
Synthesis, crystal and electronic properties of isomers of chloro-pyridinylvinyl-1H-indoles, in Abstracts, The sixth Belgian Crystallography Symposium (BCS-6), 13 October 2010, Brussels, Belgium
Laurence MOINEAUX, Caroline CHARLIER, Eduard DOLUSIC, Pierre LARRIEU, Luc PILOTTE, Didier COLAU, Vincent STROOBANT, Moreno GALLENI, Bernard MASEREEL, Benoît VAN DEN EYNDE, Johan WOUTERS, Raphael FRÉDÉRICK
2010
Diagnosis of platelet disorders by flow cytometry (including prenalytical aspects), in Joint meeting Belgian Society of Thrombosis and Haemostasis and Belgian Society of Clinical Biology
Bernard CHATELAIN, François MULLIER
2010
Etude des microparticules sur les cytomètres de nouvelle génération, in Abstract Book-11ème Colloque Rhône-Alpes de quantimétrie cellulaire-Saint-Etienne
François MULLIER, Bernard CHATELAIN
2010
A survey of last generation FCM performances to study microparticles, in 56th Annual Scientific and StandardizationCommittee Meeting (SSC) of the International Society of Thrombosis and Hemostasis (ISTH), Cairo
François MULLIER, Nicolas BAILLY, Jean-Michel DOGNÉ, Bernard CHATELAIN
2010
Study of small particles by flow cytometry: Present and future, in Abstract Book International Society for Analytical Cytology (ISAC 2010), Seattle
François MULLIER, Jean-Michel DOGNÉ, Nicolas BAILLY, Yvan CORNET, Severine ROBERT, Bernard CHATELAIN
2010
RECRUITMENT AND ACTIVATION OF SYSTEMIC NEUTROPHILS DURING THE EARLY PHASE OF WOUND HEALING AFTER SINUS SURGERY, in Abstract Book Royal Belgian Society for Ear,Nose, Throat, Head and Neck Surgery 2010
François MULLIER, Yvan CORNET, Philippe ELOY, Youri GLUPCZYNSKI, Bernard CHATELAIN, Jean-Baptiste WATELET
2010
Contribution of telemedecine to External Quality Assessment Scheme for blood smear and bone marrow interpretation: the Belgian experience
Bernard CHATELAIN, François MULLIER, Marjan VANBLERK
2010
Diagnostic et suivi des gammapathies monoclonales, in Siemens Academy 2010
François MULLIER, Bernard CHATELAIN
2010
Design, synthesis and study of inhibitors of tryptophan 2,3-dioxygenase (TDO), a promising target for cancer therapy, in Abstracts, école doctorale Structure et Fonction des Macromolécules Biologiques, Bioinformatique et Modélisation (SFMBBM), Liège, Belgium, 10 December 2010
Laurence MOINEAUX, Caroline CHARLIER, Eduard DOLUSIC, Pierre LARRIEU, Luc PILOTTE, Didier COLAU, Vincent STROOBANT, Moreno GALLENI, Bernard MASEREEL, Benoît VAN DEN EYNDE, Raphael FRÉDÉRICK
2010
Flow cytometry and its applications, in - Belgian Haematological Society, BHS course, Supportive care and laboratory medicine, Bruxelles
François MULLIER, Bernard CHATELAIN
2010
Indole-pyridinyl-ethanones as Novel Inhibitors of Indoleamine 2,3-Dioxygenase (IDO), a Promising Target for Anti-Cancer Immunotherapy, in Book of Abstracts, XXIVth European Colloquium on Heterocyclic Chemistry, Vienna, Austria, August 23-27, 2010, pp. PO-41
Eduard DOLUSIC, Sébastien BLANC, Pierre LARRIEU, Laurence MOINEAUX, Delphine COLETTE, Graeme FRASER, Vincent STROOBANT, Luc PILOTTE, Didier COLAU, Johan WOUTERS, Bernard MASEREEL, Benoît VAN DEN EYNDE, Raphael FRÉDÉRICK
2009
Contribution of Platelet Microparticles Generation Assay to the Diagnosis of Type II Heparin-induced Thrombocytopenia., in Abstract Book - Annual Meeting of Belgian Society on Thrombosis and Haemostasis
François MULLIER, Nicolas BAILLY, Yvan CORNET, Eric DUBUC, Severine ROBERT, Jean-Claude OSSELAER, Christian CHATELAIN, Bernard CHATELAIN
2009
Effects of leaf extracts from Croton zambesicus on hemostasis., in Abstract book - 23èmes Journées Franco-Belges de Pharmacochimie
Severine ROBERT, Chiara BACCELLI, Philippe DEVEL, Jean-Michel DOGNÉ, Joëlle QUETIN-LECLERCQ
2009
Interest of mepacrine testing in the storage-pool disease, in ESCCA 2009 Saint-Etienne France
François MULLIER, Véronique LATGER-CANNARD, Yvan CORNET, Bailly BAILLY, Bernard CHATELAIN
2009
Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs ? , in Abstract book - Annual Meeting of Belgian Society on Thrombosis and Haemostasis
Severine ROBERT, Jérémie GHIOTTO, Bernard PIROTTE, Jean-Louis DAVID, Bernard MASEREEL, Lionel POCHET, Jean-Michel DOGNÉ
2009
Cytologie des syndromes myélodysplasiques avec ider(20q)., in Groupe Français d'Hématologie Cellulaire (GFHC) 2009 Bruxelles
François MULLIER, Sylvie DALIPHARD, Richard GARAND, Mélanie DEKEYSER, Yvan CORNET, Isabelle LUQUET, Pascaline TALMANT, Steven RICHEBOURG, Mauricette JAMAR, Jean-Michel DOGNÉ, Christian CHATELAIN, Lucienne MICHAUX, Bernard CHATELAIN
2009
A novel algorithm to improve diagnosis of hereditary spherocytosis, in Focus Diagnostica 2009
François MULLIER, Jean-Michel DOGNÉ, Bernard CHATELAIN
2009
Platelets and microparticles, in Molecular Biology and Cytometry Course, ABCA/BVAC 2009
François MULLIER, Jean-Michel DOGNÉ, Bernard CHATELAIN
2009
Application of the case manager concept to the diagnosis of hereditary spherocytosis, in Sysmex European Haematology Symposium 2009, Istanbul (Turkey)
François MULLIER, Jean-Michel DOGNÉ, Bernard CHATELAIN
2009
Platelet microparticles quantification., in Abstract Book-European Society of Clinical Cell Analysis (ESCCA) 2009
François MULLIER, Nicolas BAILLY, Jean-Michel DOGNÉ, Bernard CHATELAIN
2008
A potential new drug delivery system for cancer therapy: biotin-labelled beta-cyclodextrin. , in Abstract book - Small Molecules, Antibodies and Natural Products: Multiple Faces of Medicinal Chemistry
Carine BERTOLLA, Severine ROBERT, Lionel POCHET, Bernard MASEREEL
2008
Contribution of platelet microparticles assay to heparin-induced thrombocytopenia diagnosis, in Wyeth Symposium 2008
François MULLIER, Yvan CORNET, Bernard CHATELAIN
2008
Nanotoxico: Toxicological assessment of engineered nanoparticles using in vitro and in vivo models.
Stéphanie ROLIN, Bernard MASEREEL, Sebastien VANKONINGSLOO, Jean-Pascal PIRET, Stephane LUCAS, Olivier TOUSSAINT
2008
Mediterranean Macrothrombocytopenia, in Abstract Book-Association Française de Cytométrie 2008
François MULLIER, Bernard CHATELAIN
2008
High-speed cell sorting, in BD sorter User's meeting 2008
François MULLIER, Nicolas BAILLY, Jean-Michel DOGNÉ, Bernard CHATELAIN
2008
Quality improvement and reduction TAT by using digitalised microscopy, in Goffin-Meyvis Symposium 2008 (Sjobo, Sweden)
François MULLIER, Bernard CHATELAIN
2008
Application of the boron neutron capture therapy to the carbonic anhydrase IX, in Abstract book - XIII International Conference on Boron Chemistry, pp. P014
Julien DEGLIM, Anne THIRY, Johan WOUTERS, Bernard MASEREEL
2008
Design, synthesis and pharmacological evaluation of novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors., in Abstract book - Small Molecules, Antibodies and Natural Products: Multiple Faces of Medicinal Chemistry
Severine ROBERT, Carine BERTOLLA, Bernard MASEREEL, Jean-Michel DOGNÉ, Lionel POCHET
2008
Contribution of platelet microparticles assay to type II HIT, in Abstract Book-Association Belge de Cytologie Analytique 2008 (ABCA/BVAC)
François MULLIER, Nicolas BAILLY, Yvan CORNET, Severine ROBERT, Jean-Michel DOGNÉ, Bernard CHATELAIN
2008
Contribution du test de génération de microparticules plaquettaires au diagnostic de thrombopénie induite par l'héparine de type II. , in Abstract Book-GEHT 2008 (Groupe Etude Hemostase Thrombose)
François MULLIER, Yvan CORNET, Christian CHATELAIN, Bernard CHATELAIN
2008
Résultats d'une étude tricentrique sur le système INR : Intérêt d'un kit de contrôle et de calibration, in Abstract Book-Groupe Etude Hemostase Thrombose 2008
Hassan MEKOUAR, François MULLIER, Yvan CORNET, Eric DUBUC, Marc CHATELAIN, Mélanie DEKEYSER, Patrick VANDEKERKOVE, Bernard CHATELAIN
2007
Towards new leads for selective carbonic anhydrase IX inhibition: synthesis, pharmacological evaluation and combined ligand-based and target-based approach, in Abstract Book-New Drugs and Drug Candidates : Recent Achievements in Medicinal Chemistry
Anne THIRY, Marie LEDECQ, Jean-Michel DOGNÉ, Claudiu T. SUPURAB, Johan WOUTERS, Bernard MASEREEL
2007
Thrombin activity profile: a rapid, reliable and relevant ex vivo screening test for the development of anticoagulant drugs, in Abstract Book-13th Belgian Forum of Pharmaceutical Sciences
Severine ROBERT, Jérémie GHIOTTO, Bernard PIROTTE, Jean-Louis DAVID, Bernard MASEREEL, Lionel POCHET, Jean-Michel DOGNÉ
2007
Carbonic anhydrase inhibitors: synthesis, biological evaluation and rational drug design to target the tumor-associated CA IX, in Abstract Book-13th Belgian Forum of Pharmaceutical Sciences
Anne THIRY, Marie LEDECQ, Jean-Michel DOGNÉ, claudiu T. SUPURAN, Johan WOUTERS, Bernard MASEREEL
2007
Inhibiteurs d'anhydrases carboniques. Evaluation de l'effet anticonvulsivant d'indanesulfonamides, in Abstract Book-21èmes Journées Franco-Belges de Pharmacochimie
Anne THIRY, Aurélie FRANKART, Catherine MICHAUX, Jean-Michel DOGNÉ, Claudiu T. SUPURAN, Johan WOUTERS, Bernard MASEREEL
2007
Application of the boron neutron capture therapy to the carbonic anhydrases, in Abstract Book-13th Belgian Forum of Pharmaceutical Sciences
Julien DEGLIM, Anne THIRY, Johan WOUTERS, Bernard MASEREEL
2007
Microwave assisted medicinal chemistry: application to the synthesis of coumarins and cyclodextrins, in Abstract Book-New Drugs and Drug Candidates: Recent Achievements in Medicinal Chemistry
Carine BERTOLLA, Severine ROBERT, Lionel POCHET, Bernard MASEREEL
2007
Le BM-573, un antagoniste original de récepteur au thromboxane A2, réduit le développement des lésions athéromateuses chez des souris déficientes en apolipoprotéine E (Apo E-/-)., in Abstract book - XXIèmes Journées franco-belges de pharmacochimie
Céline CHERDON, Stéphanie ROLIN, Julien HANSON, Pierre-Vincent DRION, Laurence DE LEVAL, Jean-Olivier DEFRAIGNE, Jean-Michel DOGNÉ
2007
Étude structurale de l'inhibition du facteur XII et de la thrombine, protéases à sérine plasmatiques, in Abstract book of 21èmes Journées Franco-Belges de Pharmacochimie
Catherine MICHAUX, Marie DEL TEDESCO, Severine ROBERT, Lionel POCHET, Johan WOUTERS
2007
Nouvelles coumarines 3-carboxamides en tant qu'inhibiteurs de facteur XIIa, in Abstract Book-21èmes Journées Franco-Belges de Pharmacochimie
Severine ROBERT, Carine BERTOLLA, Bernard MASEREEL, Jean-Michel DOGNÉ, Lionel POCHET
2007
Le profil d'activité de thrombine: un puissant test de criblage ex vivo pour le développement d'agents anticoagulants, in Abstract Book-21èmes Journées Franco-Belges de Pharmacochimie
Severine ROBERT, Jérémie GHIOTTO, Bernard PIROTTE, Jean-Louis DAVID, Bernard MASEREEL, Lionel POCHET, Jean-Michel DOGNÉ
2007
Thrombin activity profile: a powerful ex vivo screening test for the development of anticoagulant drugs, in Abstract Book-XXIst Congress of the International Society on Thrombosis and Haemostasis
Severine ROBERT, Jérémie GHIOTTO, Bernard PIROTTE, Jean-Louis DAVID, Bernard MASEREEL, Lionel POCHET, Jean-Michel DOGNÉ
2007
Nouveaux senseurs chimiques à base de beta-cyclodextrines comportant un motif coumarine. Synthèse, détermination structurale et étude des variations spectroscopiques, in Abstract Book-21ème Journées Franco-Belges de Pharmacochimie
Carine BERTOLLA, Lionel POCHET, Bernard MASEREEL
2007
Pharmacological evaluation of 6-chloromethyl-coumarins bearing a basic moiety in the 3-position as new anticoagulant drugs, in Abstract Book-New Drugs and Drug Candidates: Recent Achievements in Medicinal Chemistry
Severine ROBERT, Raphael FRÉDÉRICK, Bernard MASEREEL, Jean-Michel DOGNÉ, Lionel POCHET
2007
Beta-cyclodextrin coupled to oxytocine: synthesis and pharmacological evaluation of a new potential drug carrier system, in Abstract Book-13th Belgian Forum of Pharmaceutical Sciences
Carine BERTOLLA, Stéphanie ROLIN, Lionel POCHET, Bernard MASEREEL
2006
The use of an apoE-deficient (apoE-/-) mice model to charaterize the therapeutic benefits of original thromboxane modulators. , in Abstract book - Bioforum, pp. 123
Céline CHERDON, Stéphanie ROLIN, Julien HANSON, Laurence DE LEVAL, Pierre-Vincent DRION, Joel PINCEMAIL, Jean-Michel DOGNÉ, Jean-Olivier DEFRAIGNE
2006
Évaluation pharmacologique de la beta-cyclodextrin couplée à l'ocytocine en tant que nouveau véhicule moléculaire, in Abstract Book - XXèmes Journées Franco-Belges de Pharmacochimie
Carine BERTOLLA, Stéphanie ROLIN, Lionel POCHET, Bernard MASEREEL
2006
Développement d'inhibiteurs sélectifs de thrombine : optimisation du substituant en position P1, in Abstract Book-20èmes Journées Franco-Belges de Pharmacochimie
Severine ROBERT, Raphael FRÉDÉRICK, Bernard MASEREEL, Lionel POCHET
2005
Structure-based design of coumarins as potent thrombin inhibitors, in Abstract Book-19èmes Journées Franco-Belges de Pharmacochimie
Raphael FRÉDÉRICK, Severine ROBERT, Caroline CHARLIER, Jerome DE RUYCK, Bernard MASEREEL, Lionel POCHET
2005
Purification de beta-cyclodextrines monofonctionnalisées par chromatographie échangeuse ionique : étude comparative , in Abstract Book-19èmes Journées Franco-Belges de Pharmacochimie
Carine BERTOLLA, Anne-Marie MURRAY, Lionel POCHET, Bernard MASEREEL
2005
Évaluation biologique de coumarines en tant qu'inhibiteurs du complexe facteur tissulaire/facteur VIIa, in Abstract Book-19èmes Journées Franco-Belges de Pharmacochimie
Severine ROBERT, Raphael FRÉDÉRICK, Bernard MASEREEL, Lionel POCHET
2005
Developpement d'indanesulfonamides inhibiteurs de l'anhydrase carbonique IX, in Abstract Book-19èmes Journées Franco-Belge de pharmacochimie
Anne THIRY, Marie LEDECQ, Celine CHAZALETTE, Johan WOUTERS, Claudiu T. SUPURAN, Bernard MASEREEL
2004
Coumarins as serine protease inhibitors, in Abstract Book-XVIIIth International Symposium on Medicinal Chemistry
Lionel POCHET, Raphael FRÉDÉRICK, Severine ROBERT, Stéphanie ROLIN, Bernard MASEREEL
2004
Conception, synthèse et évaluation pharmacologique d'une sulfonylurée nitrobenzénique originale modulatrice de la voie du TXA2 en tant qu'agent anti-asthmatique potentiel., in Abstract book - XVIIIèmes Journées franco-belges de pharmacochimie
Stéphanie ROLIN, Michel PÉTEIN, Jean-Michel DOGNÉ, Catherine MICHAUX, Caroline VASTERSHAEGER, Bernard MASEREEL
2004
Synthesis of new cyanoguanidine beta-cyclodextrin derivatives, in Abstract Book-12th International Cyclodextrin Symposium
Carine BERTOLLA, Lionel POCHET, Bernard MASEREEL
2004
Nouveaux dérivés cyanoguanidines de beta-cyclodextrines, in Abstract Book-18ème Journées Franco-Belges de Pharmacochimie
Carine BERTOLLA, Lionel POCHET, Bernard MASEREEL
2004
Coumarins as inhibitors of serine proteases of the coagulation cascade, in Abstract Book-XVIIIth International Symposium on Medicinal Chemistry
Raphael FRÉDÉRICK, Severine ROBERT, Caroline CHARLIER, Bernard MASEREEL, Lionel POCHET
2004
Étude du mode d'interaction de coumarines avec la thrombine, in Abstract Book-18èmes Journées Franco-Belges de Pharmacochimie
Raphael FRÉDÉRICK, Caroline CHARLIER, Jerome DE RUYCK, Marc DIEU, Severine ROBERT, Bernard MASEREEL, Lionel POCHET
2004
Evaluation pharmacologique chez le cobaye d'une sulfonylurée originale (BM-520) apparentée au torasémide en tant qu'antagoniste du récepteur du TXA2. , in Abstract book - XVIIIèmes journées franco-belges de pharmacochimie
Caroline VASTERSAEGHER, Jean-Michel DOGNÉ, Julien HANSON, Bernard MASEREEL, Stéphanie ROLIN
2004
Évaluation biologique de dérivés coumariniques en tant qu'inhibiteurs de protéases à sérine de la cascade de la coagulation, in Abstract Book-18èmes Journées Franco-Belges de Pharmacochimie
Severine ROBERT, Raphael FRÉDÉRICK, Bernard MASEREEL, Lionel POCHET
2003
Effect of BM-573, a dual TXA2 synthase inhibitor and TXA2 receptor antagonist on infarct size in a porcine model of coronary thrombosis induced by ferric chloride., in Abstract book - Meeting de la Société Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques
Stéphanie ROLIN, Jean-Michel DOGNÉ, Michel PÉTEIN, Jacques DELARGE, Bernard MASEREEL
2003
Synthèse et réactivité de N-acyloxazolidines dérivées d'alpha-aminoacides: importance des effets stéréoélectroniques, in Abstract Book of 10ème Journée Jeunes Chercheurs
Carine BERTOLLA, Jimmy SÉLAMBAROM, Jean Pierre ROQUE, André A PAVIA
2003
Synthèse de beta-cyclodextrines modifiées, in Abstract Book-17èmes Journées Franco-Belges de Pharmacochimie
Carine BERTOLLA, Marie PIETTE, Brigitte EVRARD, Luc DELATTRE, Géraldine PIEL, Raphael FRÉDÉRICK, Bernard MASEREEL
2001
Synthèse et évaluation pharmacologique d'un méthanesulfonamide pyridinique apparenté à l'acide niflumique, in Abstract Book-XVèmes Journées Franco-Belges de Pharmacochimie, pp. 49
Fabien JULÉMONT, Xavier DE LEVAL, Philippe NEVEN, Philippe DEVEL, Bernard PIROTTE, Jacques DELARGE, Bernard MASEREEL, Catherine MICHAUX, Jean-Michel DOGNÉ
2001
Pharmacological effects of BM-593, a novel sulfonylurea acting as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor on human platelets and isolated smooth muscles., in Abstract book - XVèmes Journées franco-belges de pharmacochimie
Stéphanie ROLIN, Bernard MASEREEL, Jacques DELARGE, Jean-Michel DOGNÉ
2001
Comparaison de l'effet de deux dérivés de l'acide 6-(acétoxyméthyl)-2-oxo-2H-1-benzopyrane-3-carboxylique sur l'inhibition de l'invasion cellulaire in vitro et in vivo, in Abstract Book-XVèmes Journées Franco-Belges de Pharmacochimie, pp. 73
Isabelle KEMPEN, Serge POCHET, D PAPAPOSTOLOU, Stéphane COUNEROTTE, Bernard MASEREEL, Jean-Michel FOIDART, Michèle REBOUD-RAVAUX, Francis FRANKENNE, Bernard PIROTTE
2001
Dérivés pyridiniques et benzéniques de l'amiloride : synthèse et évaluation pharmacologique exploratoire en tant qu'inhibiteurs de l'échange sodium-proton, in Abstract Book-XVèmes Journées Franco-Belges de Pharmacochimie, pp. 74
Didier LAECKMANN, Françoise ROGISTER, Jacques DELARGE, Bernard MASEREEL
2001
Towards new leads for selective cyclooxygenase-2 (COX-2) inhibition, in Abstract Book-XVèmes Journées Franco-Belges de Pharmacochimie, pp. 84
Catherine MICHAUX, Stéphanie ROLIN, Xavier DE LEVAL, Bernard MASEREEL, François DURANT, Johan WOUTERS
2001
Préparation et évaluation pharmacologique d'analogues benzéniques de l'amiloride substitués sur l'azote distal de la foncxtion acylguanidine en tant qu'inhibiteurs de l'échange sodium-calcium, in Abstract Book-XVèmes Journées Franco-Belges de Pharmacochimie, pp. 75
Didier LAECKMANN, Françoise ROGISTER, Jacques DELARGE, Bernard MASEREEL
2001
Pharmacological profile of BM-567, a novel thromboxane A2 receptor antagonist and thromboxane A2 receptor antagonist and thromboxane A2 synthase inhibitor on the human platelets and isolated smooth muscles, in Abstract book - Meeting de la Société Belge de Physiologie et de Pharmacologie Fondamentales et Cliniques
Stéphanie ROLIN, Jean-Michel DOGNÉ, Jacques DELARGE, Bernard MASEREEL
2001
Pharmacological effect of BM-593, a novel sulfonylurea acting as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor on human platelets and isolated smooth muscles, in Abstract Book-XVèmes Journées Franco-Belges de Pharmacochimie, pp. 78
Stéphanie ROLIN, Jean-Michel DOGNÉ, Jacques DELARGE, Bernard MASEREEL
2001
Effects of thromboxane A2 receptor antagonists and COX inhibitors on osteogenic sarcoma cell-induced platelet aggregation, in Abstract Book-XVèmes Journées Franco-Belges de Pharmacochimie., pp. 69
Xavier DE LEVAL, Jacques DELARGE, Philippe NEVEN, Catherine MICHAUX, Bernard MASEREEL, Bernard PIROTTE, Jean-Louis DAVID, Jean-Michel DOGNÉ
2001
In vitro biological evaluation of two cyclooxygenase-2 inhibitors, in Abstract book - XIVèmes Journées franco-belges de pharmacochimie
Stéphanie ROLIN, Carine MICHIELS, Bernard MASEREEL, Xavier DE LEVAL, François DURANT, Catherine MICHAUX
2001
Antiplatelet and antithrombotic properties of BM-573, a novel combined thromboxane receptor antagonist and thromboxane synthase inhibitor, in Abstract Book-XVèmes Journées Franco-Belges de Pharmacochimie, pp. 70
Jean-Michel DOGNÉ, Patricia BENOIT, Xavier DE LEVAL, Philippe NEVEN, Stéphanie ROLIN, Catherine MICHAUX, Jean-Louis DAVID, Jacques DELARGE, Bernard MASEREEL
2001
Biological evaluation of a novel sulfonylurea, BM-567, with a dual activity on thromboxane A2 synthase and receptor, in Abstract book - 10ème Forum de la Société Belge des Sciences Pharmaceutiques
Stéphanie ROLIN, Jean-Michel DOGNÉ, Xavier DE LEVAL, Jacques DELARGE, Bernard MASEREEL
2000
BM-573, a novel potent dual acting agent for thromboxane A2 receptor antagonism and thromboxane A2 synthase inhibition, in Abstract book-9ème Forum de la Société Belge des Sciences Pharmaceutiques
Stéphanie ROLIN, Jean-Michel DOGNÉ, Jacques DELARGE, Bernard MASEREEL
2000
BM-531, a novel sulfonylurea acting as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, in Abstract book - XIVèmes Journées franco-belges de pharmacochimie
Stéphanie ROLIN, Jean-Michel DOGNÉ, Jacques DELARGE, Bernard MASEREEL
1999
Evaluation d'une nouvelle sulfonylcyanoguanidine en tant qu'antagoniste du thromboxane A2., in Abstract book - XIIIèmes Journées franco-belges de pharmacochimie
Stéphanie ROLIN, Jean-Michel DOGNÉ, Philippe NEVEN, Xavier DE LEVAL, Jacques DELARGE, Bernard MASEREEL

Scientific reviews

2010
Quantification du fibrinogène par électrophorèse capillaire, in Groupe Etude Hémostase Thrombose, Dijon, October 22-23th; 2010
Massin LEBITASY, François MULLIER, Hassan MEKOUAR, Diane MAISIN, Bernard CHATELAIN, Dominique LATINNE, Stéphane EECKHOUDT
2010
Recruitment and activation of sytemic neutrophils during the early phase of wound healing after sinus surgery., in NARILIS symposium. Faculté de Médecine. FUNDP Namur. October 23th, 2010
François MULLIER, Yvan CORNET, Nicolas BAILLY, Philippe ELOY, Youri GLUPCZYNSKI, Bernard CHATELAIN, Jean-Baptiste WATELET
2010
The tick protein Ir-CPI efficiently delays contact pathway induced thrombin generation and displays in vivo antithrombotic activity, in 49) NARILIS symposium. Faculté de Médecine. FUNDP Namur. October 23th, 2010
Severine ROBERT, Yves DECREM, Géraldine RATH, Chantal DESSY, Olivier FERON, François MULLIER, Philippe DEVEL, Bernard CHATELAIN, Jean-Michel DOGNÉ, Edmond GODFROID
2010
The calibrated thrombin generation test (cTGT) : a gold standard assay to assess the procoagulant activity of nanomaterials, in 50) NARILIS symposium. Faculté de Médecine. FUNDP Namur. October 23th, 2010
Julie LALOY, Severine ROBERT, Catherine MARBEHANT, François MULLIER, Jorge Humberto MEJIA MENDOZA, Jean-Pascal PIRET, Joseph DELHALLE, Stephane LUCAS, Bernard CHATELAIN, Jean-Michel DOGNÉ, Olivier TOUSSAINT, Bernard MASEREEL, Stéphanie ROLIN
2010
How to measure platelet microparticles by flow cytometry? Principles and comparison of instrument performances, in European Society for Clinical Cell Analysis, Valencia, September 2010
François MULLIER, Jean-Michel DOGNÉ, Nicolas BAILLY, Damien GHELDOF, Yvan CORNET, Bernard CHATELAIN
2010
STRUCTURAL AND ENZYMATIC STUDY OF TRYPTOPHAN 2,3- DIOXYGENASE (TDO), A POTENTIAL TARGET IN ANTICANCER IMMUNOTHERAPY, in Drugs of the Future, volume 35, issue suppl. A, pp. 217-218
Laurence MOINEAUX, Caroline CHARLIER, Eduard DOLUSIC, Pierre LARRIEU, Luc PILOTTE, Didier COLAU, Vincent STROOBANT, Moreno GALLENI, Bernard MASEREEL, Benoît VAN DEN EYNDE, Johan WOUTERS, Raphael FRÉDÉRICK
2010
Implication of tissue-factor bearing microparticles in thrombosis associated with breast cancer , in European Society for Clinical Cell Analysis, Valencia, September 2010
François MULLIER, Damien GHELDOF, Séverine ROBERT, Nicolas BAILLY, Philippe DEVEL, Bernard CHATELAIN, Jean-Michel DOGNÉ
2010
ABSOLUTE B-LYMPHOCYTE COUNTS IN CRONIC LYMPHOCYTIC LEUKEMIA: COMPARISON OF SINGLE-PLATFORM AND DUAL-PLATFORM METHODS, in European Society of Clinical Cell Analysis, Valencia, September 2010
Hassan MEKOUAR, Quentin DINON, Nicolas BAILLY, Yvan CORNET, François MULLIER, Bernard CHATELAIN
2010
External Quality Assessment Scheme for blood smear interpretation: the Belgian experience
Marjan VANBLERK, Bernard CHATELAIN, François MULLIER
2010
CLINICAL EVALUATION OF THE FULLY AUTOMATED LIAISON® ANTI-CARDIOLIPINE ASSAY, in Abstract Book-7th International Congress on Autoimmunity
François MULLIER, Hassan MEKOUAR, Bernard CHATELAIN
2010
Development of a simple flow cytometry DRAQ5-based DNA content analysis and application to Acute Lymphoblastic Leukemia , in Abstract Book Belgian Haematological Society 2010
Monia CHENAIS, François MULLIER, Bernard CHATELAIN
2010
Recruitment and activation of systemic neutrophils after sinus surgery, in Abstract book. ERS-ISIAN Congress; International Convention Center Geneva (Switzerland). June 2010.
François MULLIER, Jean-Baptiste WATELET, Yvan CORNET, Philippe ELOY, Youri GLUPCZYNSKI, Bernard CHATELAIN
2010
Comparaison de la vitesse de sédimentation de deux automates par rapport à la méthode de Westergren, in Corata, Marseille September 2010:
Hassan MEKOUAR, Catherine ROLIN, Javier HERNANDEZ, Yvan CORNET, François MULLIER, Bernard CHATELAIN
2010
Discovery and Optimization Of Indole-pyridinyl-ethanones as Novel Inhibitors of Indoleamine-2,3-Dioxygenase (IDO), a Promising Target for Anti-Cancer Immunotherapy, in Drugs of the Future, volume 35, issue suppl. A, pp. 181-182
Raphael FRÉDÉRICK, Sébastien BLANC, Pierre LARRIEU, Laurence MOINEAUX, Delphine COLETTE, Graeme FRASER, Vincent STROOBANT, Luc PILOTTE, Didier COLAU, Johan WOUTERS, Bernard MASEREEL, Benoît VAN DEN EYNDE, Eduard DOLUSIC
2010
Mesure de la vitesse de sédimentation en cas de myélome actif : Sensibilité du VES-Matic® et du Roller® par rapport à la méthode de Westergren, in Corata, Marseille September 2010:
Hassan MEKOUAR, Catherine ROLIN, Javier HERNANDEZ, Yvan CORNET, François MULLIER, Bernard CHATELAIN
2010
Implication of tissue-factor bearing microparticles in thrombosis associated with breast cancer , in Belgian Society of Clinical Biology, Anvers, October 16th; 2010
François MULLIER, Damien GHELDOF, Severine ROBERT, Nicolas BAILLY, Philippe DEVEL, Carine MICHIELS, Chantal DOYEN, Chatelain CHRISTIAN, Bernard CHATELAIN, Jean-Michel DOGNÉ
2010
Smudged cells in chronic lymphocytic leukeamia: use of flow cytometry to clarify the situation , in European Society for Clinical Cell Analysis, Valencia, September 2010
Hassan MEKOUAR, Quentin DINON, Nicolas BAILLY, Yvan CORNET, François MULLIER, Bernard CHATELAIN
2010
HOW TO MEASURE PLATELET MICROPARTICLES BY FLOW CYTOMETRY? PRINCIPLES AND COMPARISON OF INSTRUMENT PERFORMANCES , in Belgian Society of Clinical Biology, Anvers, October 16th; 2010
François MULLIER, Nicolas BAILLY, Jean-Michel DOGNÉ, Bernard CHATELAIN
2010
Assessment AND comparison of automated immunological and functional assays for factor XIII determination, in Abstract Book- Belgian Haematological Society 2010
Marie-Hélène VANDEPUT, Jean-Sébastien GOFFINET, François MULLIER, Bernard CHATELAIN
2010
Platelet Microparticle Generation Assay: a valuable and simpler alternative to 14C-SRA for type-II HIT diagnosis., in Belgian Society of Clinical Biology, Anvers, October 16th; 2010
François MULLIER, Nicolas BAILLY, Yvan CORNET, Severine ROBERT, Jean-Claude OSSELAER, Christian CHATELAIN, Ismail ELALAMY, Jean-Michel DOGNÉ, Bernard CHATELAIN
2009
A novel concept to improve diagnosis of Hereditary Spherocytosis., in Abstract Book-Société Belge Biologie Clinique 2009
François MULLIER, Nicolas BAILLY, Yvan CORNET, Jean-Michel DOGNÉ, Bernard CHATELAIN
2009
Mediteranean Macrothrombocytopenia., in Abstract Book-Belgian Haematological Society 2009
François MULLIER, Bernard CHATELAIN
2009
Interest of the quantification of Thymidine Kinase by enzyme-labeled immunoassay in Chronic Lymphoid Leukemia., in Abstract Book-Belgian Haematological Society 2009
Mélanie DEKEYSER, François MULLIER, Bernard CHATELAIN
2009
Apport de la cytométrie en flux dans le diagnostic d'un lymphome T angio-immunoblastique (LTAI) avec envahissement sanguin et médullaire : cas clinique et revue de la littérature., in Abstract Book-Belgian Haematological Society 2009
François MULLIER, Yvan CORNET, Bernard CHATELAIN
2009
Assessment of BCR-ABL protein by flow cytometry and comparison with QRT-PCR in chronic myelogenous leukemia, in Abstract Book-Belgian Haematological Society 2009
François MULLIER, Pierre BOGAERTS, Bernard CHATELAIN
2009
Accurate quantification of microparticles by flow cytometry: important issues. , in Journal of Thrombosis and Haemostasis, volume 7, issue 2, pp. 329
François MULLIER, Jean-Michel DOGNÉ, Nicolas BAILLY, Yvan CORNET, Severine ROBERT, Bernard CHATELAIN
2009
Synthesis, molecular modeling and pharmacological evaluation of pyrazoloisoquinolines as potential anti-polyarthritis drugs
Jérémie MORTIER, Corinne GANEFF, Caroline REMOUCHAMPS, Emmanuel DEJARDIN, Patrice TALAGA, Jacques PIETTE
2009
Potential nanotoxicity in blood : Effects of engineered nanoparticles on human blood constituents, in Nanofac 2009
Julie LALOY, Catherine MARBEHANT, Severine ROBERT, François MULLIER, Bernard CHATELAIN, Jean-Michel DOGNÉ, Olivier TOUSSAINT, Bernard MASEREEL, Stéphanie ROLIN
2009
Pyrazolo(4,3-c)isoquinolines as potential inhibitors of NF-kB activation
Jérémie MORTIER, Raphaël FREDERICK, Corinne GANEFF, Caroline REMOUCHAMPS, Patrice TALAGA, Jacques PIETTE, Bernard MASEREEL
2008
Apport de la cytométrie en flux dans le diagnostic de sphérocytose héréditaire., in Abstract Book-Association Française de Cytométrie 2008
Nicolas BAILLY, François MULLIER, Bernard CHATELAIN
2008
Microwave assisted medicinal chemistry : application to the synthesis of coumarins and cyclodextrins, in Chimie Nouvelle, volume 98, pp. 25-25
Carine BERTOLLA, Severine ROBERT, Lionel POCHET, Bernard MASEREEL
2008
Contribution of flow cytometry in the diagnosis of hereditary spherocytosis., in Abstract Book-Association Belge de Cytologie Analytique (ABCA-BVAC) 2008
François MULLIER, Nicolas BAILLY, Bernard CHATELAIN
2008
Mediteranean Macrothrombocytopenia, in Abstract Book-ABCA/BVAC 2008
François MULLIER, Bernard CHATELAIN
2008
Pharmacological evaluation of 6-chloromethyl-coumarins bearing a basic moeity in the 3-position as new anticoagulants drugs, in Chimie Nouvelle, volume 98, pp. 26-26
Severine ROBERT, Raphael FRÉDÉRICK, Bernard MASEREEL, Jean-Michel DOGNÉ, Lionel POCHET
2008
Towards new leads for selective carbonic anhydrase IX inhibition: synthesis, pharmacologcal evaluation and combined ligand-based and target-based approach., in Chimie Nouvelle, volume 98, pp. 26-26
Anne THIRY, Marie LEDECQ, Jean-Michel DOGNÉ, Claudiu SUPURAN, Johan WOUTERS, Bernard MASEREEL
2008
Analyse des liquides corporels sur le XS1000i®, in Abstract Book-Société Française d'Hématologie 2008
François MULLIER, Yvan CORNET, Bernard CHATELAIN
2008
Evaluation de 4 méthodes sérologiques dans le diagnostic de thrombopénie induite par l'héparine (TIH2)., in Abstract Book-Groupe Etude Hemostase Thrombose 2008
Julie HOTTON, François MULLIER, Bernard CHATELAIN
2008
rt-PCR in diagnosis of alpha-thalassemia : a future alternative?, in Abstract Book-Brussels 2008
Hassan MEKOUAR, François MULLIER, Caroline DEBECKER, Marianne PHILIPPE
2008
Inaccuracy of Mean Cell Volume on XE-2100, in Abstract Book-Société Belge de Biologie Clinique 2008
François MULLIER, Yvan CORNET, Bernard CHATELAIN
2008
Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors, in Drugs of the Future, volume 33, issue suppl A, pp. 266
Severine ROBERT, Carine BERTOLLA, Bernard MASEREEL, Jean-Michel DOGNÉ, Lionel POCHET
2008
Evaluation de l'intérêt clinique du Multiplate®., in Abstract Book-Groupe Etude Hemostase Thrombose 2008
Stéphanie WINAND-LIBAN, François MULLIER, Bernard CHATELAIN
2008
Résistance à l'héparine due à un excès de facteur VIII lors d'une circulation extracorporelle chez un patient infecté. , in Abstract Book-Groupe Etude Hemostase Thrombose 2008
Anne-Sophie DINCQ, François MULLIER, Bernard CHATELAIN
2008
Structural insights into the inhibition mode of the activated coagulation factor XII by coumarins, in Drugs of the Future, volume 33, issue suppl A, pp. 267
Catherine MICHAUX, Severine ROBERT, Marie DEL TEDESCO, Bernard MASEREEL, Jean-Michel DOGNÉ, Lionel POCHET
2008
Apport de la cytométrie en flux dans le diagnostic d'un lymphome T angio-immunoblastique (LTAI) avec envahissement sanguin et médullaire : cas clinique et revue de la littérature., in Abstract Book-Association Française de Cytométrie 2008
François MULLIER, Yvan CORNET, Bernard CHATELAIN
2008
Biotin tagged beta-cyclodextrin: a potential new drug targeting system for tumor therapy, in Drugs of the Future, volume 33, issue suppl. A, pp. 259
Carine BERTOLLA, Lionel POCHET, Bernard MASEREEL
2008
Contribution of platelet microparticles assay to type II HIT, in Abstract Book-Platelet 2008 International Symposium
François MULLIER, Yvan CORNET, Bernard CHATELAIN
2007
Reference change values and disease specific cut off for CA125assays, in Abstract Book-ISOBM 2007; International Society for Oncodevelopmental Biology and Medicine
François MULLIER, Jérémie GRAS
2007
Thrombin activity profile: a powerful ex vivo screening test for the development of anticoagulant drugs, in Journal of Thrombosis and Haemostasis, volume 5, issue Suppl. 2, pp. PW-073
Severine ROBERT, Jérémie GHIOTTO, Bernard PIROTTE, Jean-Louis DAVID, Bernard MASEREEL, Lionel POCHET, Jean-Michel DOGNÉ
2007
Good Clinical Use of CA125: Reference Change values, impact of endometriosis and interest of a double cut-off, in Clinical Chemistry
François MULLIER, Jérémie GRAS, Marianne PHILIPPE
2007
Biological and analytical variability of CA 15.3 antigen: influence on cut-offs and reference change values., in Clin Chem Lab Med, volume 45, pp. S373
François MULLIER, Jérémie GRAS, Marianne PHILIPPE
2007
Evaluation of three immunoassays to quantify tacrolimus: impact of hematocrit , in Abstract Book-IATDMCT 2007 (International Congress of Therapeutic Drug Monitoring & Clinical Toxicology)
Jean-Sébastien GOFFINET, François MULLIER, Pierre WALLEMACQ
2007
Definition of clinical threshold for CMV Real-Time PCR after comparison with pp65 antigenemia and clinical data., in Abstract Book-Société Belge de Biologie Clinique 2007
François MULLIER, Benoit KABAMBA, Monique BODEUS, Patrick GOUBAU
2007
Biological and analytical variability of CA 15.3 antigen: influence on cut-offs and reference change values., in Clinical Chemistry
François MULLIER, Jeremie GRAS, Marianne PHILIPPE
2007
Biological and Analytical variations of CA15.3 assays : influence on cutoffs and reference change value, in Abstract Book-ISOBM 2007; International Society for Oncodevelopmental Biology and Medicine
François MULLIER, Jérémie GRAS, Marianne PHILIPPE
2007
CA125 assays: Reference Change values, interest of disease specific cut off levels., in Clin Chem Lab Med, volume 45, pp. S353
François MULLIER, Jeremie GRAS, Marianne PHILIPPE
2006
Design, synthesis and biological evaluation of indanesulfonamides as carbonic anhydrase IX inhibitors, in Fundamental and Clinical Pharmacology, volume 20, pp. 626
Anne THIRY, Marie LEDECQ, Alessandro CECCHI, Jean-Michel DOGNÉ, Johan WOUTERS, Claudiu T. SUPURAN, Bernard MASEREEL
2004
Coumarins as serine protease inhibitors, in Drugs of the future, volume 29, issue A, pp. 171
Lionel POCHET, Raphael FRÉDÉRICK, Severine ROBERT, Stéphanie ROLIN, Bernard MASEREEL
2004
Insight into the mode of action of coumarins as thrombin inhibitors, in Fundamental and Clinical Pharmacology, volume 18, pp. 595
Raphael FRÉDÉRICK, Caroline CHARLIER, Jerome DE RUYCK, Marc DIEU, Severine ROBERT, Bernard MASEREEL, Lionel POCHET
2004
Coumarins as inhibitors of serine proteases of the coagulation cascade, in Drugs of the future, volume 29 , issue A, pp. 172
Raphael FRÉDÉRICK, Severine ROBERT, Caroline CHARLIER, Bernard MASEREEL, Lionel POCHET
2004
Synthesis of new cyanoguanidine beta-cyclodextrin derivatives, in Proceedings of the 12th International cyclodextrins symposium , pp. 159-162
Carine BERTOLLA, Lionel POCHET, Bernard MASEREEL
2004
Synthesis and pharmacological evaluation of original thromboxane A2 receptor antagonists derived from BM-573., in Fundamental and Clinical Pharmacology, volume 18, pp. 593-599
Julien HANSON, Jean-François RENARD, Stéphanie ROLIN, Philippe NEVEN, Xavier DE LEVAL, Jean-Michel DOGNÉ, Bernard PIROTTE, Jean-Michel DOGNÉ
2003
Antithrombotic activity of BM-573, a novel thromboxane modulator, in rat arterial thrombosis model, pig myocardial infarction model and its effects on bleeding time, in Blood, volume November suppl, issue n°4213
Jean-Michel DOGNÉ, Philippe KOLH, Stéphanie ROLIN, Vincent TCHANA-SATO, Julien HANSON, Xavier DE LEVAL, Bernard LAMBERMONT, Alexandre GHUYSEN, Michel PÉTEIN, Laurence DE LEVAL, Bernard MASEREEL, Bernard PIROTTE
2003
A dual thromboxane inhibitor and thromboxane receptor antagonist prevents pig myocardial infarction induced by coronary thrombosis, in European Heart Journal, volume 24, pp. 325
Stéphanie ROLIN, Michel PÉTEIN, Vincent TCHANA-SATO, Jean-Michel DOGNÉ, Bernard LAMBERMONT, Alexandre GHUYSEN, Philippe KOLH, Bernard MASEREEL
2003
A dual thromboxane inhibitor and thromboxane receptor antagonist prevents pig myocardial infarction induced by coronary thrombosis, in Basic Research in Cardiology, volume 98, pp. 189
Stéphanie ROLIN, Michel PÉTEIN, Vincent TCHANA-SATO, Jean-Michel DOGNÉ, Bernard LAMBERMONT, Alexandre GHUYSEN, Philippe KOLH, Bernard MASEREEL
2003
Haemodynamic effect of thromboxane A2 inhibition in acute pulmonary embolism, in European Journal of Heart Failure, volume 2, issue 1, pp. 150
Alexandre GHUYSEN, Bernard LAMBERMONT, Philippe KOLH, Bernard MORIMONT, Vincent TCHANA-SATO, Jean-Michel DOGNÉ, Stéphanie ROLIN, Vincent D'ORIO
2003
Effect of BM-573, a dual TXA2 synthase inhibitor and TXA2 receptor antagonist on infarct size in a porcine model of coronary thrombosis by ferric chloride, in Pfllüg. Arch. - European Journal of Physiology, volume 446, pp. R4
Stéphanie ROLIN, Michel PETEIN, Jean-Michel DOGNÉ, Vincent TCHANA-SATO, Philippe KOLH, Bernard MASEREEL
2003
BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane a2 receptors, in Blood, volume November suppl, issue n°3013
Julien HANSON, Stéphanie ROLIN, Xavier DE LEVAL, Philippe NEVEN, Laurence DE LEVAL, Bernard MASEREEL, Bernard PIROTTE, Jean-Michel DOGNÉ
2002
Antithrombotic properties of BM-573 an original dual thromboxane receptor antagonist and thromboxane synthase inhibitor, in Pathophysiology of Haemostasis and Thrombosis, volume 32, issue (S2), pp. 60
Jean-Michel DOGNÉ, Patricia BENOIT, Xavier DE LEVAL, Stéphanie ROLIN, Philippe KOLH, Alexandre GHYSEN, Vincent TCHANA-SATO, Bernard MASEREEL
2002
Anti-platelet and antithrombotic properties of the nitrobenzenic sulfonylurea BM-573, in Fundamental and Clinical Pharmacology, volume 16, pp. 245
Jean-Michel DOGNÉ, Patricia BENOIT, Xavier DE LEVAL, Stéphanie ROLIN, Philippe NEVEN, Philippe KOLH, Bernard MASEREEL, Jean-Louis DAVID
2002
Design and pharmacological evaluation of a novel combined thromboxane A2 receptor antagonist and thromboxane synthase inhibitor derived from torasemide as promising antiplatelet agent, in Blood, volume 96, issue 11, pp. 230
Jean-Michel DOGNÉ, Xavier DE LEVAL , Stéphanie ROLIN, Philippe NEVEN, Philippe KOLH, Jean-Louis DAVID, G FILLET, Jacques DELARGE, Bernard MASEREEL
2001
Pharmacological evaluation of BM-573 an original dual thromboxane receptor antagonist and thromboxane synthase inhibitor as novel potent antithrombotic agent, in Blood, volume december, issue suppl
Jean-Michel DOGNÉ, Xavier DE LEVAL, Patricia BENOIT, Philippe NEVEN, Laurence DE LEVAL, Stéphanie ROLIN, Jean-Louis DAVID, Bernard MASEREEL
2001
Pharmacological profile of BM-567, a novel thromboxane A2 receptor antagonist and thromboxane A2 synthase inhibitor on the human platelets and isolated smooth muscle, in Fundamental and Clinical Pharmacology, volume 15, pp. 363
Stéphanie ROLIN, Jean-Michel DOGNÉ, Jacques DELARGE, Bernard MASEREEL
2001
Pharmacological evaluation of original sulfonylureas as thromboxane A2 antagonists, in Fundamental and Clinical Pharmacology, volume 300, pp. 14
Jean-Michel DOGNÉ, Xavier DE LEVAL, Philippe NEVEN, Fabian SOMERS, Jacques DELARGE, Stéphanie ROLIN, Catherine MICHAUX, Johan WOUTERS, Bernard PIROTTE, Jacques DAMAS, Bernard MASEREEL
2001
Design and pharmacological evaluation of an original non-carboxylic thromboxane receptor antagonist and thromboxane synthase inhibitor as promising antiplatelet agent, in Thrombosis and Haemostasis, issue July suppl, pp. P1630
Jean-Michel DOGNÉ, Xavier DE LEVAL, Stéphanie ROLIN, Philippe NEVEN, Philippe KOLH, Jean-Louis DAVID, Jacques DELARGE, Bernard MASEREEL
2000
Characterization of the antiplatelet activity of ticlopidine and acetylsalicylic acid by PFA-100, in Fundamental and Clinical Pharmacology, volume 14, pp. 168
Jean-Michel DOGNÉ, Xavier DE LEVAL, Philipp NEVEN, Stéphanie ROLIN, Jean-Louis DAVID, Jacques DELARGE, Bernard MASEREEL
2000
Inhibition of cellular invasion by 3-chlorophenyl 6-(acétoxymethyl)-2-oxo-2H-1-benzopyran-3-carboxylate, in European Journal of Physiology, volume 440, issue 78, pp. R252
Isabelle KEMPEN, Lionel POCHET, D PAPAPOSTOLU, Nicole BOGETTO, Caroline DOUCET, Bernard MASEREEL, Jean-Michel FOIDART, Michèle REBOUD-RAVAUX, Francis FRANKENNE, Bernard PIROTTE
2000
Evaluation of classical NSAIDs on COX-1 and COX-2 purified enzymes and prognosis of their effects on physiological responses, in Fundamental and Clinical Pharmacology, volume 14, pp. 167
Xavier DE LEVAL, Yves HENROTIN, Bernard MASEREEL, Fabian SOMERS, Philippe NEVEN, Philippe DEVEL, Jacques DELARGE, Jean-Michel DOGNÉ
2000
BM-144, a novel thromboxane A2 receptor antagonist relaxes trachea guinea pig in vitro, in Journal of Allergy and Clinical Immunology, volume 105, pp. S21-S21
Jean-Michel DOGNÉ, Xavier DE LEVAL, Philippe NEVEN, Stéphanie ROLIN, Jacques DELARGE, Bernard MASEREEL
2000
Design, synthesis and pharmacological evalution of original thromboxane receptor antagonists., in Mediators of Inflammation, volume 9, pp. 53
Jean-Michel DOGNÉ, Xavier DE LEVAL, Jacques DELARGE, Jean-Yves REGINSTER, Yves HENROTTIN, Philippe NEVEN, Stéphanie ROLIN, Bernard MASEREEL
2000
Pharmacological evaluation of original sulfonylureas as thromboxane A2 antagonists, in Fundamental and clinical Pharmacology, volume 14, pp. 300
Jean-Michel DOGNÉ, Xavier DE LEVAL, Philippe NEVEN, Fabian SOMERS, Jacques DELARGE, Stéphanie ROLIN, Catherine MICHAUX, Johan WOUTERS, Bernard PIROTTE, Jacques DAMAS, Bernard MASEREEL
2000
Profile of nimesulide and nimesulide beta-cyclodextrin on chondrocyte metabolism., in Fundamental and Clinical Pharmacology, volume 14, pp. 169
Xavier DE LEVAL, Jean-Michel DOGNÉ, Bernard MASEREEL, Jean-Yves REGINSTER, Philippe NEVEN, A LABASSE, Jacques DELARGE, Yves HENROTIN
1999
PFA-100, a novel pharmacological tool for characterization of antiplatelet potency of thromboxane receptor antagonists, in Blood, volume 94 (suppl 1), pp. 3626
Jean-Michel DOGNÉ, Xavier DE LEVAL, Jacques DELARGE, Philippe NEVEN, Stéphanie ROLIN, Jean-Louis DAVID, Georges FILLET, Bernard MASEREEL
1998
Insulinotropic effect of glibenclamide isosteres, in Fundamental and Clinical Pharmacology, volume 12, pp. 307
Q.A. NGUYEN, Lionel POCHET, Raogo OUEDRAOGO, Mark J. DUNNE, Bernard MASEREEL, Philippe LEBRUN, Marie-Hélène ANTOINE

PHD theses

2011
Development & validation of pharmacological tools for the preclinical testing of anticoagulants
Severine ROBERT
2010
Design, synthesis molecular modelling and biological evaluation of modulators of the NF-kappa activation
Jérémie MORTIER, J.Y. WINUM
2010
Monofunctionalizations of beta-cyclodextrin, conjugation with recognition patterns, and biological evaluation
Carine BERTOLLA
2008
Conception, synthèse et évaluation pharmacologique d'inhibiteurs originaux des anhydrases carboniques de type VII et IX
Anne THIRY
2008
Design, synthesis and pharmacological evaluation of carbonic anhydrase VII and IX inhibitors
Anne THIRY
2006
Synthèse et étude de coumarines 3,6-disubstituées en tant qu'inhibiteurs de thrombine basés sur le mécanisme
Raphael FRÉDÉRICK
2004
Conception, synthèse et évaluation biologique de 2-thiohydantoïnes en tant qu'inhibiteurs potentiels des cyclooxygénases
Marie-Pierre GAUTHIER
2003
Evaluation pharmacologique de molécules apparentées au torasémide en tant que modulateurs de la voie du thromboxane A2: du criblage in vitro à l'évaluation in vivo de sulfonylurées nitrobenzéniques
Stéphanie ROLIN

Student theses

2011
Synthèse de b-carbolines trisubstituées en tant que nouveaux agents antiprolifératifs
Pierre LEGRAND
2010
Synthèse d'inhibiteurs d'indoleamine-2,3-dioxygenases (IDO et TDO) deux enzymes dont les propriétés immunosuppressives en font des cibles majeures pour le traitement du cancer
Sara MODAFFARI
2010
Synthèse d'inhibiteurs d'indoleamine-2,3-dioxygenases (IDO et TDO) deux enzymes dont les propriétés immunosuppressives en font des cibles majeures pour le traitement du cancer
Sara MODAFFARI, Eduard DOLUSIC
2010
Synthèse et étude d'inhibiteurs sélectifs de l'anhydrase carbonique de type IX (CA IX), une nouvelle cible potentielle pour le traitement du cancer.
Manuel CONSTANT
2009
Etude du rôle des médiateurs apparentés au thromboxane dans l'athérosclérose: effets de modulateurs originaux sur les cellules endothéliales et les cellules musculaires vasculaires
Christophe COPINE
2009
Impact potentiel de nanoparticules manufacturées sur le sang et ses éléments. HECE - Section Biologie médicale
Laurie TAYENNE
2007
Evaluation pharmacologique de modulateurs de la cascade de l'acide arachidonique sue cellules endothéliales et dans un modèle murin d'athérosclérose.
Stéphanie GENON
2006
Evaluation pharmacologique d'indanesulfonamides en tant qu'inhibiteurs d'anhydrases carboniques
Aurélie FRANKART
2006
Synthèse de coumarine-3-carboxamide
Nicolas GRÉGOIRE
2004
Evaluation biologique de coumarines en tant qu'inhibiteurs de protéases à sérine de la cascade de la coagulation
Severine ROBERT
2004
Evaluation pharmacologique de modulateurs de la cascade de l'acide arachidonique
Caroline VASTERSAEGHER
2003
Evaluation in vitro et in vivo de l'activité antithrombotique de nouveaux dérivés coumariniques
Marina MOREL
2003
Conception, synthèse et évaluation biologique de coumarines en tant qu'inhibiteur de thrombine
Raphael FRÉDÉRICK
2002
QCM en ligne
Christian POCHET
2001
Rationalisation du mode d'action de dérivés pyridiniques du nimésulide en vue de concevoir une famille originale d'inhibiteurs sélectifs de la cyclooxygénase-2
Caroline CHARLIER
2001
Evaluation biologique de modulateurs de la cascade de l'acide arachidonique: (DEA en sciences pharmaceutiques)
Stéphanie ROLIN
2000
Etude de l'inhibition de l'alpha-chymotrypsine par les dérivés de la coumarine
Jérémie CUISENAIRE
2000
Conception, synthèse et évaluation pharmacologique de dérivés originaux du torasémide à propriétés antagonistes du thromboxane A2 et inhibitrices de la thromboxane synthétase
Jean-Michel DOGNÉ
2000
Formation et utilisation de liposomes pour l'étude de la lipophilie de principes actifs
Gaëtan HENRY
1999
Les protéases à sérine: contribution à l'étude du mécanisme d'inhibition de la chymotrypsine par des dérivés de type coumarinique
Marjorie HUYGENS
1999
Analyse structurale et électronique au moyen de méthodes physico-chimiques expérimentales et théoriques de l'interaction entre le récepteur du thromboxane et ses antagonistes
Catherine MICHAUX
1999
Evaluation biologique d'antagonistes du récepteur du thromboxane A2
Stéphanie ROLIN

Student coursebooks

2007
Notes de Cours de Biochimie
Bernard MASEREEL
2007
Note de cours de Chimie Pharmaceutiques - Médicaments Biosynthétiques
Bernard MASEREEL
2007
Exercices de Technologie Pharmaceutique
Severine ROBERT, Jean-Michel DOGNÉ
2007
Notes de Cours d'Introduction aux Sciences Pharmaceutiques
Bernard MASEREEL
2007
Note de cours d'Analyse Pharmaceutique
Bernard MASEREEL, Lionel POCHET
2006
Travaux Dirigés de Biochimie Générale
Severine ROBERT, Anne-Marie MURRAY, Bernard MASEREEL
2006
Notes de cours de Pharmacognosie
Monique TITS
2006
Séminaires de Biochimie Humaine
Severine ROBERT, Stéphanie ROLIN, Jean-Michel DOGNÉ
2006
Travaux Pratiques de Micrographie appliquée à la Pharmacognosie
Severine ROBERT, Monique TITS
2005
Travaux Pratiques de Biochimie Générale
Severine ROBERT, Anne-Marie MURRAY, Bernard MASEREEL

Research reports

2005
Etude de fixation des coumarines sur l'alpha-chymotrypsine
Marianne CRESPIN

Multimedia

2010
Programme européen e-hematimage:Multiple myeloma
François MULLIER, Hassan MEKOUAR, Yvan CORNET, Bernard CHATELAIN
2009
programme européen e-hematimage: Mediterranean Macrothrombocytopenia
François MULLIER, Bernard CHATELAIN
2009
Matériel et manipulations en labos pharmaceutiques [DVD]
Severine ROBERT, Philippe DEVEL, Julien DEGLIM, Bernard MASEREEL, Pauline SOVET, Didier LEPIÈCE, Monique NOIRHOMME-FRAITURE
2009
programme européen e-hematimage: Binucleated lymphocytosis
François MULLIER, Bernard CHATELAIN
2008
Programme européen e-hematimage: Secondary ALL
François MULLIER, Bernard CHATELAIN